The present invention relates to microfabrication of microscale devices and reactions in microscale devices, and in particular, movement of biological samples in microdroplets through microchannels to initiate biological reactions.
The complexity and power of biological reactions has increased dramatically over the last thirty years. The initial observations of the “hybridization” process, i.e., the ability of two polymers of nucleic acid containing complementary sequences to find each other and anneal through base pairing interaction, by Marmur and Lane, Proc. Nat. Acad. Sci., U.S.A. 46, 453 (1960) and Doty et al. Proc. Nat. Acad. Sci., U.S.A. 46, 461 (1960), have been followed by the refinement of this process into an essential tool of modern biology.
Initial hybridization studies, such as those performed by Hayashi et al., Proc. Nat. Acad. Sci., U.S.A. 50, 664 (1963), were formed in solution. Further development led to the immobilization of the target DNA or RNA on solid supports. With the discovery of specific restriction endonucleases by Smith and Wilcox, J. Mol. Biol. 51, 379 (1970), it became possible to isolate discrete fragments of DNA. Utilization of immobilization techniques, such as those described by Southern, J. Mol. Biol. 98, 503 (1975), in combination with restriction enzymes, has allowed for the identification by hybridization of singly copy genes among a mass of fractionated, genomic DNA.
In 1977, two methods for DNA sequencing were reported. These were the chemical degradation method of Maxam and Gilbert (1977 Proc. Natl. Acad Sci, USA 74:560) and the enzymatic method of Sanger et al. (1977, Proc. Natl. Acad Sci. USA 74:5463). Both methods generate populations of radiolabeled oligonucleotides which begin at a fixed point and terminate randomly at a fixed residue or type of residue. These populations are resolved on polyacrylamide gels which allow the discrimination between oligonucleotides that differ in length by as little as one nucleotide.
The Maxam and Gilbert method utilizes a fragment of DNA radiolabeled at one end which is partially cleaved in five separate chemical reactions, each of which is specific for a particular base or type of base. The products of these chemical reactions are five populations of labelled molecules that extend from the labeled end to the site of chemical cleavage. This method has remained relatively unchanged since its initial development. This method works best for DNA sequences that lie less than 250 nucleotides from the labeled end.
In contrast, the Sanger method is capable of sequencing greater than 500 nucleotides in a single set of reactions. The Sanger method is an enzymatic reaction that utilizes chain-terminating dideoxynucleotides (ddNTPs). ddNTPs are chain-terminating because they lack a 3′-hydroxyl residue which prevents formation of a phosphodiester bond with the succeeding deoxyribonucleotide (dNTP). A small amount of one ddNTP is included with the four conventional dNTPs in a polymerization reaction. Polymerization or DNA synthesis is catalyzed by a DNA polymerase. There is competition between extension of the chain by incorporation of the conventional dNTPs and termination of the chain by incorporation of a ddNTP. A short oligonucleotide or primer is annealed to a template containing the DNA to be sequenced. The original protocols required single-stranded DNA templates. The use of double-stranded templates was reported later (Chen and Seeburg 1985). The primer provides a 3′ hydroxyl group which allows the polymerization of a chain of DNA when a polymerase enzyme and dNTPs are provided.
The original version of the Sanger method utilized the Klenow fragment of E. coli DNA polymerase. This enzyme has the polymerization and 3′ to 5′ exonuclease activity of the unmodified polymerase but lacks 5′ to 3′ exonuclease activity. The Klenow fragment has several limitations when used for enzymatic sequencing. One limitations is the low processivity of the enzyme, which generates a high background of fragments that terminate by the random dissociation of the enzyme from the template rather than by the desired termination due to incorporation of a ddNTP. The low processivity also means that the enzyme cannot be used to sequence nucleotides that appear more than ˜250 nucleotides from the 5′ end of the primer. A second limitation is that Klenow cannot efficiently utilize templates which have homopolymer tracts or regions of high secondary structure. The problems caused by secondary structure in the template can be minimized by running the polymerization reaction at 55° C. (R. Gomer and R. Firtel, “Sequencing homopolymer regions.” Bethesda Res. Lab. Focus 7:6 1985).
Improvements to the original Sanger method include the use of polymerases other than the Klenow fragment. Reverse transcriptase has been used to sequence templates that have homopolymeric tracts (S. Karanthanasis, “M13 DNA sequencing using reverse transcriptase” Bethesda Res. Lab. Focus 4(3):6 1982; Graham et al., “Direct DNA sequencing using avian myeloblastosis virus and Moleney murine leukemia virus reverse transcriptase” Bethesda Res. Lab. Focus 8(2):4 1986). Reverse transcriptase is somewhat better than the Klenow enzyme at utilizing templates containing homopolymer tracts.
The use of a modified T7 DNA polymerase (Sequenase™) was the most significant improvement to the Sanger method. See Sambrook, J. et al. Molecular Cloning, A Laboratory Manual, 2d Ed. Cold Spring Harbor Laboratory Press, New York, 13.7-13.9 and Hunkapiller, M. W. (1991) Curr. Op. Gen. Devl. 1:88-92. Sequenase™ is a chemically-modified T7 DNA polymerase has reduced 3′ to 5′ exonuclease activity (Tabor et al. 1987, Proc. Natl. Acad. Sci. USA 84:4767). Sequenase™ version 2.0 is a genetically engineered form of the T7 polymerase which completely lacks 3′ to 5′ exonuclease activity. Sequenase™ has a very high processivity and high rate of polymerization. It can efficiently incorporate nucleotide analogs such as dITP and 7-deaza-dGTP which are used to resolve regions of compression in sequencing gels. In regions of DNA containing a high G+C content, Hoogsteen bond formation can occur which leads to compressions in the DNA. These compressions result in aberrant migration patterns of oligonucleotide strands on sequencing gels. Because these base analogs pair weakly with conventional nucleotides, intrastrand secondary structures are alleviated. In contrast, Klenow does not incorporate these analogs as efficiently. The main limitation to the amount of DNA sequence that can be obtained from a single set of chain-termination reactions using Sequenase™ is the resolving power of polyacrylamide gels, not the properties of the enzyme.
The use of Taq DNA polymerase is a more recent addition to the improvements of the Sanger method (Innis et al. 1988, Proc. Natl. Acad. Sci. USA 85:9436). Taq polymerase is a thermostable enzyme which works efficiently at 70-75° C. The ability to catalyze DNA synthesis at elevated temperature makes Taq polymerase useful for sequencing templates which have extensive secondary structures at 37° C. (the standard temperature used for Klenow and Sequenase™ reactions). Taq polymerase, like Sequenase™, has a high degree of processivity and like Sequenase 2.0, it lacks 3′ to 5′ nuclease activity.
Methods were also developed for examining single base changes without direct sequencing. These methods allow for the “scanning” of DNA fragments for the presence of mutations or other sequence variation. For example, if a mutation of interest happens to fall within a restriction recognition sequence, a change in the pattern of digestion can be used as a diagnostic tool (e.g., restriction fragment length polymorphism [RFLP] analysis).
With the development of these complex and powerful biological techniques, an ambitious project has been undertaken. This project, called the Human Genome Project (HGP), involves the complete characterization of the archetypal human genome sequence which comprises 3×109 DNA nucleotide base pairs. An implicit goal of the project is the recognition that all humans are greater than 99% identical at the DNA sequence level. The differences between people, however, provide the information most relevant to individual health care, including potential estimates of the risk of disease or the response to a specific medical treatment. Upon completion of the HGP, a continuing effort of the human genetics research community will be the examination of differences within populations and of individual variants from the defined archetype. While the 15-year effort of the HGP represents a defined quantity of DNA data acquisition, the future demand for DNA information is tied to individual genetic variation and is, therefore, unlimited.
Current DNA genotyping technologies are adequate for the detailed analysis of samples that range in number from hundreds to thousands per year. Genotyping projects on the order of millions of assays, however, are beyond the capabilities of today's laboratories because of the current inefficiencies in (i) liquid handling of reagent and DNA template solutions, (ii) measurement of solution volumes, (iii) mixing of reagent and template, (iv) controlled thermal reaction of the mixed solutions, (v) sample loading onto an electrophoresis gel, and (vi) DNA product detection on size-separating gels. What is needed is methodology that allows for a high-volume of biological reactions without these existing inefficiencies.
The present invention relates to microfabrication of micro scale devices and reactions in microscale devices, and in particular, movement of biological samples in microdroplets through microchannels to initiate biological reactions. The present invention contemplates microscale devices, comprising microdroplet transport channels, reaction regions (e.g. chambers), electrophoresis modules, and radiation detectors. In a preferred embodiment, these elements are microfabricated from silicon and glass substrates. The various components are linked (i.e., in liquid communication) using a surface-tension-gradient mechanism in which discrete droplets are differentially heated and propelled through etched channels. Electronic components are fabricated on the same substrate material, allowing sensors and controlling circuitry to be incorporated in the same device. Since all of the components are made using conventional photolithographic techniques, multi-component devices can be readily assembled into complex, integrated systems.
It is not intended that the present invention be limited by the nature of the reactions carried out in the microscale device. Reactions include, but are not limited to, chemical and biological reactions. Biological reactions include, but are not limited to sequencing, restriction enzyme digests, RFLP, nucleic acid amplification, and gel electrophoresis. It is also not intended that the invention be limited by the particular purpose for carrying out the biological reactions. In one medical diagnostic application, it may be desirable to differentiate between a heterozygotic and homozygotic target and, in the latter case, specifying which homozygote is present. Where a given genetic locus might code for allele A or allele a, the assay allows for the differentiation of an AA from an Aa from an aa pair of alleles. In another medical diagnostic application, it may be desirable to simply detect the presence or absence of specific allelic variants of pathogens in a clinical sample. For example, different species or subspecies of bacteria may have different susceptibilities to antibiotics; rapid identification of the specific species or subspecies present aids diagnosis and allows initiation of appropriate treatment.
The present invention contemplates a method for moving microdroplets, comprising: (a) providing a liquid microdroplet disposed within a microdroplet transport channel etched in silicon, said channel in liquid communication with a reaction region via said transport channel and separated from a microdroplet flow-directing means by a liquid barrier; and (b) conveying said microdroplet in said transport channel to said reaction region via said microdroplet flow-directing means. It is intended that the present invention be limited by the particular nature of the microdroplet flow-directing means. In one embodiment, it comprises a series of aluminum heating elements arrayed along said transport channel and the microdroplets are conveyed by differential heating of the microdroplet by the heating elements.
It has been found empirically that the methods and devices of the present invention can be used with success when, prior to the conveying described above the transport channel (or channels) is treated with a hydrophilicity-enhancing compound. It is not intended that the invention be limited by exactly when the treatment takes place. Indeed, there is some flexibility because of the long-life characteristics of some enhancing compounds.
Again, it has been found empirically that there is a need for a liquid barrier between the liquid in the channels and the electronics of the silicon chip. A preferred barrier comprises a first silicon oxide layer, a silicon nitride layer, and a second silicon oxide layer.
The present invention further contemplates a method for merging microdroplets comprising: (a) providing first and second liquid microdroplets, a liquid microdroplet delivering means, and a device, said device comprising: i) a housing comprised of silicon, ii) first and second microdroplet transport channels etched in said silicon and connecting to form a third transport channel containing a reaction region, iii) a microdroplet receiving means in liquid communication with said reaction region via said transport channels, and iv) microdroplet flow-directing means arrayed along said first, second and third transport channels; (b) delivering said first liquid microdroplet via said microdroplet delivering means to said first transport channel; (c) delivering said second liquid microdroplet via said microdroplet delivering means to said second transport channel; and (d) conveying said microdroplets in said transport channels to said reaction region in said third transport channel via said microdroplet flow-directing means, thereby merging said first and second microdroplets to create a merged microdroplet.
In one embodiment, said first microdroplet comprises nucleic acid and said second microdroplet comprises a nuclease capable of acting on said nucleic acid. In this embodiment, it is desirable to enhance the mixing within the merged microdroplet. This can be achieved a number of ways. In one embodiment for mixing, after the conveying of step (d), the flow direction is reversed. It is not intended that the present invention be limited by the nature or number of reversals. If the flow direction of said merged microdroplet is reversed even a single time, this process increases the mixing of the reactants.
The present invention contemplates a variety of silicon-based, microdroplet transport channel-containing devices. In one embodiment, the device comprises: i) a housing comprised of silicon, ii) a microdroplet transport channel etched in said silicon, iii) a microdroplet receiving means in liquid communication with a reaction region via said transport channels, and iv) a liquid barrier disposed between said transport channels and a microdroplet flow-directing means. In one embodiment, the device is assembled in two parts. First, the channels are etched in any number of configurations. Secondly, this piece is bonded with a silicon-based chip containing the electronics. This allows for both customization (in the first piece) and standardization (in the second piece).
The present invention also contemplates devices and methods for the sealing of channels with meltable material. In one embodiment, the device comprises a meltable material disposed within a substrate and associated with a heating element.
In one embodiment, the present invention contemplates a method comprising: a) providing a device having a meltable material disposed within a substrate and associated with a heating element; and b) heating said meltable material with said heating element such that said meltable material at least partially liquifies and such that said substrate is not damaged. The method may further comprise c) allowing said liquified meltable material to cool. While the present invention is not limited by the size of the channel, in one embodiment said substrate further comprises a microdroplet channel disposed in said substrate, said meltable material is disposed within said microdroplet channel.
In another embodiment, the present invention contemplates a method for restricting fluid flow in a channel comprising a) providing a device comprising: i) a meltable material disposed within a substrate, said meltable material associated with a heating element; and ii) a diaphragm positioned such that, when extended, it touches said meltable material; b) extending said diaphragm such that it touches said meltable material; and c) heating said meltable material with said heating element such that said meltable material at least partially liquifies and such that said substrate is not damaged. In one embodiment the method further comprises d) allowing said meltable material to cool. While the present invention is not limited by the size of the channel, in one embodiment, the substrate further comprises a microdroplet channel disposed in said substrate, said meltable material disposed within said microdroplet channel.
The present invention also contemplates a method for restricting fluid flow in a channel, comprising: a) providing: i) a main channel connected to a side channel and disposed within a substrate, ii) meltable material disposed within said side channel and associated with a heating element, and iii) a movement means connected to said side channel such that application of said movement means induces said meltable material to flow from said side channel into said main channel; b) heating said meltable material such that said meltable material at least partially liquifies; and c) applying said movement means such that said liquified meltable material flows from said side channel into said main channel. While the present invention is not limited by the movement means, in one embodiment the movement means is forced air. In one embodiment the method further comprises d) allowing said meltable material to cool. While the present invention is not limited by the size of the channel, in one embodiment, the main channel and the side channel are microdroplet channels.
While the present invention is not limited by the nature of the substrate, in one embodiment the substrate comprises silicon or glass. Likewise, the present invention is not limited by the composition of the meltable material. In one embodiment, the meltable material comprises solder. In a preferred embodiment, the solder comprises 40:60 Sn:Pb. In other embodiments, the meltable material is selected from a group consisting of plastic, polymer and wax. Likewise, the present invention is not limited by the placement of the meltable material in the substrate. In another embodiment, the meltable material is placed adjacent to a channel, while in another embodiment it is placed near the junction of more than one channel.
Definitions
The following definitions are provided for the terms used herein:
“Biological reactions” means reactions involving biomolecules such as enzymes (e.g., polymerases, nucleases, etc.) and nucleic acids (both RNA and DNA). Biological samples are those containing biomolecules, such proteins, lipids, nucleic acids. The sample may be from a microorganism (e.g., bacterial culture) or from an animal, including humans (e.g. blood, urine, etc.). Alternatively, the sample may have been subject to purification (e.g. extraction) or other treatment. Biological reactions require some degree of biocompatability with the device. That is to say, the reactions ideally should not be substantially inhibited by the characteristics or nature of the device components.
“Chemical reactions” means reactions involving chemical reactants, such as inorganic compounds.
“Channels” are pathways through a medium (e.g., silicon) that allow for movement of liquids and gasses. Channels thus can connect other components, i.e., keep components “in liquid communication.” “Microdroplet transport channels” are channels configured (in microns) so as to accommodate “microdroplets” While it is not intended that the present invention be limited by precise dimensions of the channels or precise volumes for microdroplets, illustrative ranges for channels and microdroplets are as follows: the channels can be between 0.35 and 50 μm in depth (preferably 20 μm) and between 50 and 1000 μm in width (preferably 500 μm), and the volume of the microdroplets can range (calculated from their lengths) between approximately one (1) and (100) nanoliters (more typically between ten and fifty).
“Conveying” means “causing to be moved through” as in the case where a microdroplet is conveyed through a transport channel to a particular point, such as a reaction region. Conveying can be accomplished via flow-directing means.
“Flow-directing means” is any means by which movement of a microdroplet in a particular direction is achieved. A preferred directing means employs a surface-tension-gradient mechanism in which discrete droplets are differentially heated and propelled through etched channels.
“Hydrophilicity-enhancing compounds” are those compounds or preparations that enhance the hydrophilicity of a component, such as the hydrophilicity of a transport channel. The definition is functional, rather than structural. For example, Rain-X™ anti-fog is a commercially available reagent containing glycols and siloxanes in ethyl alcohol. However, the fact that it renders a glass or silicon surface more hydrophilic is more important than the reagent's particular formula.
“Initiating a reaction” means causing a reaction to take place. Reactions can be initiated by any means (e.g., heat, wavelengths of light, addition of a catalyst, etc.)
“Liquid barrier” or “moisture barrier” is any structure or treatment process on existing structures that prevents short circuits and/or damage to electronic elements (e.g., prevents the destruction of the aluminum heating elements). In one embodiment of the present invention, the liquid barrier comprises a first silicon oxide layer, a silicon nitride layer, and a second silicon oxide layer.
“Merging” is distinct from “mixing.” When a first and second microdroplet is merged to create a merged microdroplet, the liquid may or may not be mixed. Moreover, the degree of mixing in a merged microdroplet can be enhanced by a variety of techniques contemplated by the present invention, including by not limited to reversing the flow direction of the merged microdroplet.
“Nucleic Acid Amplification” involves increasing the concentration of nucleic acid, and in particular, the concentration of a particular piece of nucleic acid. A preferred technique is known as the “polymerase chain reaction.” Mullis et al., U.S. Pat. Nos. 4,683,195 and 4,683,202, hereby incorporated by reference, describe a method for increasing the concentration of a segment of target sequence in a mixture of genomic DNA without cloning or purification. This process for amplifying the target sequence consists of introducing a molar excess of two oligonucleotide primers to the DNA mixture containing the desired target sequence. The two primers are complementary to their respective strands of the double-stranded sequence. The mixture is denatured and then allowed to hybridize. Following hybridization, the primers are extended with polymerase so as to form complementary strands. The steps of denaturation, hybridization, and polymerase extension can be repeated as often as needed to obtain are relatively high concentration of a segment of the desired target sequence. The length of the segment of the desired target sequence is determined by the relative positions of the primers with respect to each other, and therefore, this length is a controllable parameter. By virtue of the repeating aspect of the process, the method is referred to by the inventors as the “Polymerase Chain Reaction” (hereinafter PCR). Because the desired segment of the target sequence become the dominant sequences (in terms of concentration) in the mixture, they are said to be “PCR-amplified.”
“Substrate” as used herein refers to a material capable of containing channels and microdroplet transport channels. Examples include, but are not limited to, silicon and glass.
“Meltable material” as used herein refers to a material that is at least semi-solid (and preferably completely solid) at ambient temperature, will liquify when heated to temperatures above ambient temperature, and will at least partially resolidify when cooled. Preferably, meltable material at least partially liquifies at a temperature such that the substrate is undamaged. That is to say, at the temperature the meltable material liquifies, the substrate and other metals in the substrate does not liquify (readily tested as set forth in Example 6) and does not change its properties. By “changing properties” it is meant that the substrate or metal maintains it structural integrity, does not change its conductivity and does not liquify. Thus, the characteristic of being meltable is not necessarily associated with a particular melting point. Examples include, but are not limited to, solder, wax, polymer and plastic.
“Solder” as used herein refers to a metal or alloy that is a meltable material. Preferably, the solder is a lower temperature solder, such as set forth in U.S. Pat. No. 4,967,950, herein incorporated by reference. “Lower temperature solder” means a eutectic alloy. While the present invention is not limited to a specific solder, one preferred solder composition for the paste is a 63:37 eutectic alloy of tin:lead. Another compatible solder is a 90% metal composition having a 63:35:2 eutectic alloy of tin:lead:silver. Other desired solder compositions such as eutectic Pb:Sn, Pb:In, Pb:In:Sn etc.
“Heating element” as used herein refers to an element that is capable of at least partially liquify a meltable material. A meltable material is “associated with” a heating element when it is in proximity to the heating element such that the heating element can at least partially melt the meltable material. The proximity necessary will depend on the melting characteristics of the meltable material as well as the heating capacity of the heating element. The heating element may or may not be encompassed within the same substrate as the meltable material.
“Diaphragm” as used herein refers to an element capable of being manipulated such that it can at least partially block the passage of fluid in a channel in one position (extended) and permit the flow of fluid in a channel in another position. An “actuating force” is a force that is capable of extending a diaphragm. A “valve seat” is an element designed to accept a portion of the diaphragm when extended. A “movement means” is a means capable of moving liquified meltable material (e.g., force air, magnetic field, etc.).
The present invention relates to microfabrication and biological reactions in microfabricated devices, and in particular, movement and mixing of biological samples in microdroplets through microchannels. The description of the invention involves I) design of microscale devices (comprising microdroplet transport channels, reaction chambers, electrophoresis ports, and radiation detectors) using silicon and glass substrates, II) movement of discrete microdroplets using a surface-tension-gradient mechanism in which discrete microdroplets are differentially heated and propelled through etched channels, and III) mixing of biological samples for reactions.
I. Design of MicroScale Devices
Although there are many formats, materials, and size scales for constructing integrated fluidic systems, the present invention contemplates silicon microfabricated devices as a cost-effective solution. Silicon is the material used for the construction of computing microprocessors and its fabrication technologies have developed at an unprecedented pace over the past 30 years. While this technology was initially applied to making microelectronic devices, the same techniques are currently being used for micromechanical systems.
Continuous flow liquid transport has been described using a microfluidic device developed with silicon. See J. Pfahler et al., Sensors and Actuators, A21-A23 (1990), pp. 431-434. Pumps have also been described, using external forces to create flow, based on micromachining of silicon. See H. T. G. Van Lintel et al., Sensors and Actuators 15:153-167 (1988). By contrast, the present invention employs discrete droplet transport in silicon (i.e., in contrast to continuous flow) using internal forces (i.e., in contrast to the use of external forces created by pumps).
As a mechanical building material, silicon has well-known fabrication characteristics. The economic attraction of silicon devices is that their associated micromachining technologies are, essentially, photographic reproduction techniques. In these processes, transparent templates or masks containing opaque designs are used to photodefine objects on the surface of the silicon substrate. The patterns on the templates are generated with computer-aided design programs and can delineate structures with line-widths of less than one micron. Once a template is generated, it can be used almost indefinitely to produce identical replicate structures. Consequently, even extremely complex micromachines can be reproduced in mass quantities and at low incremental unit cost—provided that all of the components are compatible with the silicon micromachining process. While other substrates, such as glass or quartz, can use photolithographic methods to construct microfabricated analysis devices, only silicon gives the added advantage of allowing a large variety of electronic components to be fabricated within the same structure.
In one embodiment, the present invention contemplates silicon micromachined components in an integrated analysis system, including the elements identified schematically in
In silicon micromachining, a simple technique to form closed channels involves etching an open trough on the surface of a substrate and then bonding a second, unetched substrate over the open channel. There are a wide variety of isotropic and anisotropic etch reagents, either liquid or gaseous, that can produce channels with well-defined side walls and uniform etch depths. Since the paths of the channels are defined by the photo-process mask, the complexity of channel patterns on the device is virtually unlimited. Controlled etching can also produce sample entry holes that pass completely through the substrate, resulting in entry ports on the outside surface of the device connected to channel structures.
II. Movement of Discrete MicroDroplets
The present invention describes the controlled movement of liquid samples in discrete droplets in silicon. Discrete droplet transport involves a system using enclosed channels or tubes to transport the liquid to the desired locations (
That is to say, forward motion can be maintained by continuing to heat the droplet at the rear surface with successive heaters along the channel, while heating the front surface can be used to reverse the motion of the droplet. Applying a voltage to the wire beneath the channel generates heat under the edge of the droplet. Heating the left interface increases the internal pressure on that end of the droplet and forces the entire droplet to the right. The pressure on the interior of the droplet can be calculated knowing the atmospheric pressure, Patm, the surface tension, σ, and the dimensions of the channel. For a circular cross-section, the interior pressure, Pi, is given by Pi=Patm−(4σ cos θ)/d where d is the diameter of the channel and θ is the contact angle. Since σ is a function of temperature (σ=σo(1−bT) where σo and b are positive constants and T is the temperature), increasing the temperature on the left end of the droplet decreases the surface tension and, therefore, increases the internal pressure on that end. The pressure difference between the two ends then pushes the droplet towards the direction of lower pressure (i.e., towards the right). The aqueous droplet shown is in a hydrophilic channel (0<θ<90); for a hydrophobic channel (90<θ<180), heating the right edge would make the droplet move to the right.
Contact angle hysteresis (the contact angle on the advancing edge of the droplet is larger than the contact angle on the retreating edge) requires a minimum temperature difference before movement will occur. The velocity of the droplet after motion begins can be approximated using the equation v=d2/32 μL where
is the pressure difference, μ is the viscosity of the solution, and L is the length of the droplet. The present invention contemplates temperature differences of greater than thirty (30) degrees Centigrade to create movement. Experiments using temperature sensors arrayed along the entire channel indicate that a differential of approximately 40° C. across the droplet is sufficient to provide motion. In these experiments, the channel cross-section was 20 μm×500 μm, and the volume of each of these droplets can be calculated from their lengths and is approximately 100 nanoliters for a 1 cm long droplet.
III. Flow Control with Sealed Valves
The present invention contemplates the use of sealed valves to control fluid flow. While the present invention is not limited to a particular sealing method, in one embodiment, an actuating force pushes a diaphragm against a valve seat to restrict fluid flow and the diaphragm is then sealed to the valve seat. In such an embodiment, the solder pads are associated with a heating element that can melt the solder. This liquified solder flows over areas of the valve seat and diaphragm to cover contamination, cracks and crooks between the diaphragm and valve seat. With the actuating force still holding the diaphragm and valve-seat together, the heating element is turned off to allow the solder to cool and re-solidify. Upon solidification, the actuating force can be released and the valve is sealed. To open the valve again, the solder can be liquified without applying an actuation force.
In a preferred embodiment, the valve is designed such that solder pads are placed on the diaphragm or valve seat. While the present invention is not limited to a precise method of placing these solder pads, it is specifically contemplated that they can be electroplated.
IV. Mixing Biological Samples in Reactions
Droplet motion (described generally above) is contemplated as one step in a pathway. The other steps typically involve sample mixing and a controlled reaction. For example, the integral heaters arrayed along the entire surface of the channel used for droplet motion also allow for a region of a channel to be used as a thermal reaction chamber. For sample mixing prior to the reaction, a Y-channel device is contemplated (
Following sample merging (
First, there is simple diffusion, although, for large DNA molecules, the characteristic time for this mixing could be on the order of several hours or more. Circulation patterns generated inside the droplets during movement and heating significantly reduce this time. In this regard, the present invention contemplates maintaining the mixture as a heated mixture (e.g., maintaining the temperature at 65° C. for 10 minutes) using the integral heaters and temperature sensors.
Second, the present invention contemplates mixing by reversing the flow direction of the mixture over a relatively short distance in the channel. While a variety of reverse flow approaches are possible, one or two direction changes over a distance comprising approximately two droplet lengths has been found to be adequate.
Finally, there is the mixing approach wherein the mixture is moved against or over physical obstacles. For example, the mixture can be either “crashed” back against merge point of the Y-channel or simply moved over deliberate imperfections in the channel (i.e., “roller coaster” mixing).
Successful mixing, of course, can be confirmed by characterization of the product(s) from the reaction. Where product is detected, mixing has been at least partially successful. The present invention contemplates, in one embodiment, using electrophoresis to confirm product formation.
The description of the preferred embodiments involves: I) microfabrication techniques for manufacture of silicon-based devices; II) channel treatment for optimum flow and reproducibility; and III) component design (particularly the electrophoresis module and the radiation detectors).
I. Microfabrication of Silicon-Based Devices
As noted previously, silicon has well-known fabrication characteristics and associated photographic reproduction techniques. The principal modern method for fabricating semiconductor integrated circuits is the so-called planar process. The planar process relies on the unique characteristics of silicon and comprises a complex sequence of manufacturing steps involving deposition, oxidation, photolithography, diffusion and/or ion implantation, and metallization, to fabricate a “layered” integrated circuit device in a silicon substrate. See e.g., W. Miller, U.S. Pat. No. 5,091,328, hereby incorporated by reference.
For example, oxidation of a crystalline silicon substrate results in the formation of a layer of silicon dioxide on the substrate surface. Photolithography can then be used to selectively pattern and etch the silicon dioxide layer to expose a portion of the underlying substrate. These openings in the silicon dioxide layer allow for the introduction (“doping”) of ions (“dopant”) into defined areas of the underlying silicon. The silicon dioxide acts as a mask; that is, doping only occurs where there are openings. Careful control of the doping process and of the type of dopant allows for the creation of localized areas of different electrical resistivity in the silicon. The particular placement of acceptor ion-doped (positive free hole, “p”) regions and donor ion-doped (negative free electron, “n”) regions in large part defines the interrelated design of the transistors, resistors, capacitors and other circuit elements on the silicon wafer. Electrical interconnection and contact to the various p or n regions that make up the integrated circuit is made by a deposition of a thin film of conductive material, usually aluminum or polysilicon, thereby finalizing the design of the integrated circuit.
Of course, the particular fabrication process and sequence used will depend on the desired characteristics of the device. Today, one can choose from among a wide variety of devices and circuits to implement a desired digital or analog logic feature.
In a preferred embodiment, channels were prepared on 500 μm thick glass wafers (Dow Corning 7740) using standard aqueous-based etch procedures. The initial glass surface was cleaned and received two layers of electron beam evaporated metal (20 nm chromium followed by 50 nm gold). Photoresist Microposit 1813 (Shipley Co.) was applied 4000 rpm, 30 seconds; patterned using glass mask 1 and developed. The metal layers were etched in chromium etchant (Cr-14, Cyantek Inc.) and gold etchant (Gold Etchant TFA, Transene Co.) until the pattern was clearly visible on the glass surface. The accessible glass was then etched in a solution of hydrofluoric acid and water (1:1, v/v). Etch rates were estimated using test wafers, with the final etch typically giving channel depths of 20 to 30 μm. For each wafer, the depth of the finished channel was determined using a surface profilometer. The final stripping (PRS-2000, J. T. Baker) removed both the remaining photoresist material and the overlying metal.
In one embodiment, channels etched on glass in the above-described manner, were bonded to the heater-element wafer in a two-part construction approach using optical adhesive (SK-9 Lens Bond, Sumers Laboratories, Fort Washington, Pa.). The bond was cured under an ultraviolet light source (365 nm) for 12 to 24 hours.
Initial device design by the present inventors involved single layers of silicon. However, experience showed these to be inadequate to prevent short circuiting due to (necessary) liquid microdroplets within the channels (see experiments described below). The preferred design involves a triple layer of oxides. Such a preferred device capable of moving and mixing nanoliter droplets was constructed by bonding a planar silicon substrate to channels etched in a glass cover. A series of metal heaters was inlaid on the silicon substrate as two parallel lanes merging into a single lane (a “Y”-shape) (
Heater elements were fabricated as follows. Silicon wafer (p-type, 18-22½-cm, 100
, boron concentration Å 1015 cm−3) was used as a substrate for growth of SiO2 thermal oxide (1 μm); photoresist (AZ-5214-E, Hoescht-Celanese) was applied and spun at 3000 rpm, 30 seconds. The resist was patterned (metal 1) and developed. Reactive ion etch (RIE, PlasmaTherm, Inc.) was performed to 0.35 μm depth into the SiO2 layer at the following conditions: CHF3, 15 sccm (standard cubic centimeters per minute); CF4, 15 sccm; 4 mTorr; DC bias voltage of 200V, 100 W, 20 minutes. The etch depth was measured by profilometer and 0.35 μm metallic aluminum was electron beam deposited. The resist and overlying metal was lifted off by development using Microposit 1112A remover in solution (Shipley Co.). The barrier layers consist of sequentially deposited 1 μm SiOx, 0.25 μm SixNy, and 1 μm SiOx, using plasma-enhanced chemical vapor deposition (PECVD). RIE was used to etch contact holes to the metal layer using a second mask (CHF3, 15 sccm; CF4, 15 sccm; 4 mTorr; and DC bias voltage of 200V, 100 W, 120 minutes).
As shown in
The heating-element wafer was bonded to a glass wafer containing etched channels with the same “Y” format. An aqueous chemical etch of concentrated hydrofluoric acid was used to produce channels with defined side walls and uniform depth. The etched channels are defined by a chromium/gold mask and are 500 μm wide and approximately 20 μm deep (
Each heating element used as a temperature sensor is preferably first calibrated by measurement of electrical resistance at 22° C. and 65° C. under constant voltage; intermediate temperatures are estimated by linear interpolation.
II. Channel Treatment
Prior to performing microdroplet motion and biological reactions, the channels are preferably treated by washing with base, acid, buffer, water and a hydrophilicity-enhancing compound, followed by a relatively high concentration solution of non-specific protein. In a preferred embodiment, the channels are washed with approximately 100 μl each of the following solutions in series: 0.1N NaOH; 0.1N HCl; 10 mM Tris-HCl (pH 8.0), deionized H2O, Rain-X Anti-Fog (a hydrophilicity-enhancing compound commercially available from Unelko Corp., Scottsdale, Ariz.), and 500 μg/μl bovine serum albumin (non-specific protein commercially available in restriction enzyme grade from GIBCO-BRL). The wafer was placed on a stereoscope stage (Olympus SZ1145), and the contact pads for the heating elements were connected to a regulated power supply. Heating occurred by passing approximately 30 volts through the element in short pulses and observing the movement rate of the droplets. A detectable reduction in droplet volume from evaporation was noted in each experiment, usually of less than 30%. Droplet movement was recorded with a Hamamatsu video camera on videotape.
III. Component Design
The present invention contemplates one or more gel electrophoresis modules as a component of the microscale device. Theoretical and empirical research has indicated that reducing the thickness of the electrophoresis channel leads to improved resolution. Thinner gels dissipate heat more readily and allow higher voltages to be used, with concomitant improvements in separation. The position and width of the electrophoresis detector are also critical to the ultimate resolution of the electrophoresis system. A micromachined electronic detector, such as a photodiode, placed in the underlying silicon substrate can be less than one micron from the gel matrix and can have a width of 5 microns or less. Since the gel length required for the resolution of two migrating bands is proportional to the resolution of the detector, the incorporation of micron-width electronic detectors can reduce the total gel length required for standard genotyping by at least an order of magnitude.
To demonstrate that standard gel electrophoresis can operate in micron-diameter channels, modules were fabricated using etched glass channels identical to
The present invention contemplates an electrophoresis unit that integrates a micromachined channel and an electronic DNA detector. The channel is constructed using a sacrificial etch process on a single silicon wafer rather than the bonded surface-etch method described earlier. In the sacrificial etch technique, the channel configuration is patterned by depositing on the wafer surface an etch-sensitive material (phosphosilicate glass, SiO2.Px) with a thickness equivalent to the desired channel height. A triple-layer overlay of plasma-enhanced chemical vapor deposited silicon nitride, undoped polycrystalline silicon, and silicon nitride (SixNy/polySi/SixNy) completely covers the sacrificial material with the exception of small access holes on the top or sides. A selective liquid etch removes the sacrificial layer material, but not the overlay or the underlying substrate. The sacrificial etch technique results in a complete channel being formed directly on the substrate containing the electronic components (
A radiation detector, consisting of a 10 μm wide “p-n”-type diode with a 5 μm wide guard ring around the outer edge, is fashioned directly into the silicon substrate underneath the channel. In this implementation, an integral radiation detector was chosen because of (i) high sensitivity (a single decay event), (ii) small aperture dimensions, and (iii) well-know fabrication and response characteristics. On this electrophoresis system, a 1 cm long, 3 μm thick gel is able to perform as separation on a 80 and a 300 base-pair fragment of DNA. It should be noted that this diode, although currently configured for high-energy beta particle detection, can also operate as a photon detector. With proper wavelength filters and light sources, detection of fluorescence emission may be accommodated with a similar device.
Radiation detectors were prepared as follows. A 200½-cm, 100
, float zone, boron-doped, p-type silicon wafer was used as a substrate. Diffused layers of phosphorus (5×1014 cm−2) and boron (1×1015 cm−2) were ion-implanted onto the sample in lithographically-defined regions; thermal silicon oxide was grown (0.2 μm at 900° C.) over the wafer; and contact holes were etched to the diffusion layer using buffered hydrofluoric acid solution (5:1). A 3.3 μm layer of Microposit 1400-37 photoresist was patterned to define the metal pads; 50 nm chromium followed by 400 nm gold was evaporated over the resist; and the metallization lifted off the regions retaining the resist. A layer of Microposit 1813 photoresist was applied across the wafer and baked for 110° C. for 30 minutes to form an aqueous solution barrier. Radioactive phosphorus (32P) decay events could be detected using a sample of labeled DNA in PCR reaction buffer placed on the photoresist layer. The detector was connected to a charge-sensitive preamplifier (EV-Products 550A), followed by a linear shaping amplifier and a standard oscilloscope.
Experimental
The following examples serve to illustrate certain preferred embodiments and aspects of the present invention and are not to be construed as limiting the scope thereof.
In the experimental disclosure which follows, the following abbreviations apply: eq (equivalents); M (Molar); μM (micromolar); N (Normal); mol (moles); mmol (millimoles); μmol (micromoles); nmol (nanomoles); gm (grams); mg (milligrams); μg (micrograms); L (liters); ml (milliliters); μl (microliters); cm (centimeters); mm (millimeters); μm (micrometers); nm (nanometers); ° C. (degrees Centigrade); Ci (Curies); MW (molecular weight); OD (optical density); EDTA (ethylenediamine-tetracetic acid); PAGE (polyacrylamide gel electrophoresis); UV (ultraviolet); V (volts); W (watts); mA (milliamps); bp (base pair); CPM (counts per minute).
This example describes approaches to the problem of forming a moisture barrier over electrical elements of the microscale device. Initial prototypes employed 5000 angstroms of aluminum and covered it with PECVD SiOx. Upon testing, it was determined that the liquids were penetrating this later and destroying the aluminum heating elements.
Without clear evidence what was causing this problem, it was hypothesized that the step height of the aluminum was causing cracks in the passivation layer (the oxide). In order to alleviate the cracking problem, a layer of SixNy was tried between two layers of SiOx, with the thought that the additional thickness would overcome the cracking caused by the step height. It did not.
As a follow-up approach, a thinner layer (500 angstroms) of aluminum was tried. This gave 1/10th the step height of the original prototype devices. On top of this aluminum, a triple layer of SiOx, SixNy, and SiOx was employed. Moreover, the process for making the SixNy layer was changed to one which would give a more dense layer. This appeared to solve the problem. However, the thinner layer of aluminum created a higher resistance which was not acceptable. It was determined that one needed a way to generate thicker layers of aluminum for lower resistance, yet keep the surface relatively smooth (planar). An etch back process was used (now called “the inlay process”) to accomplish the task. By etching back into a layer of SiOx depositing aluminum in the resulting cavity, then stripping the resist mask, a surface was obtained with a step height low enough to prevent cracking of the passivation layers.
It was also discovered that the metal bonding pads were not adhering well to the initial PECVD SiOx layer. To overcome the problem, the process was modified by using a wet thermal SiO2 layer.
This example describes approaches to enhancing droplet motion by surface treatment. In this regard, the principle of using surface tension to cause droplets to move may be applied to either hydrophilic or hydrophobic surfaces. Glass, for instance, is naturally hydrophilic with a near zero contact angle with water. Because the oxide coating of the present invention is made principally of the same material as glass, it was expected that the devices would also exhibit near zero angles. It was discovered, however, that the actual construction materials had contact angles far from zero, thus enhancing the effects of contact angle hysteresis (discussed in greater detail in Example 3). For instance, water gave a contact angle (static) of ˜42° on polyamide, ˜41° on SiO2 (major component of most glasses), ˜62° on silicone spray. To enhance the surface effectiveness, several treatment processes for both hydrophilic and hydrophobic surfaces were tried, as described below.
To improve the hydrophilicity of a surface, several cleaning procedures were tried. It has been reported that surface contamination and/or roughness can reduce the hydrophilicity of surfaces. Therefore, a high concentration chromic acid cleaning, a high concentration sulfuric acid cleaning, a baking procedure (to 600° C. for 8 hrs. to burn off contaminates), and surface coatings were tried. The acid cleaning procedures were not as effective as the baking procedure; however, neither proved to be compatible with the devices since the concentrated acids would attack the aluminum pads and the high temperature could peal the aluminum (melting pt. ˜660° C.) or break the adhesive bond between the heater chip and the channel.
Rain-X antifog (commercially available) as a treatment was observed to work. This is a surface treatment which makes surfaces hydrophilic. Although, the resulting surfaces may not be 0°, by using this coating the entire surface gets treated giving a uniform surface for the droplet. Experimentally, it was found that Rain-X antifog treatments greatly enhanced droplet motion experiments using heat. Another such treatment which was tested but which did not work was a material called SilWet. This material is used in the agriculture industry for enhancing the wetting of plants with agricultural sprays.
To obtain hydrophobic surfaces, the present inventors tried coating capillaries with Rain-X and silane treatments. Neither of these gave angles much greater than 90°, therefore, would not work with this mechanism. These treatments would have to have given angles ˜180° to be useful for hydrophobic studies of motion. Eventually, it was discovered that one could apply a teflon coating that was sufficiently hydrophobic to possibly warrant future tests.
This example describes approaches to droplet motion by heat treatment. As noted previously (above), the contact angle on the advancing end of a liquid droplet in motion (known as the advancing contact angle) is greater that the that on the receding end (receding contact angle). In the case of a hydrophilic surface—such as water on glass—this tends to create a back pressure countering attempts at forward motion by heating the back side of a droplet. This is best shown by a simple model describing laminar flow through a channel.
Average Flow Through a Circular Channel:
<v>=−ΔP*[R2/(8 μL]
where: Δ=value at back−value at front end of droplet
Therefore:
<v>=−(ΔG)*(1/R)*[R2/(8 μL)]=[−0.16*ΔT*R/(8 μL)]
It was discovered experimentally, however, that the channel dimension and fluid parameters (other than surface tension) do not affect whether or not the droplet will move. They do determine the magnitude of motion (if it occurs). What does determine whether motion will occur or not is the following inequality:
Gfront/Gback>(Rfront/Rback)*(cos βback/cos βfront)
The present calculations suggest that a ˜35° C. difference between the front and back of a droplet should be sufficient to initiate droplet motion in a system with advancing angles of 36° and receding angles of 29° in a 20 μm high channel. Experimental testing of actual devices however, showed that the front of the droplet heats relatively quickly thus reducing the temperature difference needed for movement between the front and the back of the droplet. This effect required us to use higher voltages to obtain droplet motion. Voltages typically in the range of ˜30° Volts were found to be required to obtain motion. Further experiments showed that the resulting temperature difference was ˜40° C. between the front and back of the droplet thus corroborating the initial determination of the requirements.
Discrete droplet motion in a micromachined channel structure using thermal gradients is demonstrated in the videorecorded images of
The heaters along the entire surface of the channel shown in
This example describes various approaches for bonding channels to the substrate which contains circuitry for heating and temperature sensing of the device of the present invention (see discussion of two-part construction, above). First attempts involved Polyamide; regular polyamide was unsatisfactory in that it was found the two pieces would not stick together.
Follow-up attempts involved a photo-definable Polyamide. This produced a sticky surface, but would not give a perfect seal along the channel. It was discovered that the solvents released during the final baking process were causing pockets in the polyamide layer. An adhesion layer was needed which would seal by ‘curing’ and not release solvents.
Several different epoxies and glues were investigated, as listed below.
A preferred glue was a UV cured glue, although the process of applying the UV glue is tedious and requires some practice to avoid putting the glue in places where it does not belong, e.g., in the channels.
Hydroxide bonding and screen printing of bonding substances was also attempted. Another option was glass tape, but the high temperatures required to melt the tape appeared to be too high for the present devices.
This example describes a nucleic acid amplification reaction on a silicon-based substrate. The established DNA biochemistry steps for PCR occur within physiological conditions of ionic strength, temperature, and pH. Thus, the reaction chamber components have design limitations in that there must be compatibility with the DNA, enzymes and other reagents in solution.
To assess biocompatability, components were added to a standard PCR reaction. The results (see
To form a biologically compatible heating element, the present inventors began by coating a standard silicon wafer with a 0.5 μm layer of silicon dioxide. Next, a 0.3 μm deep, 500 μm wide channel was etched into the silicon oxide and gold or aluminum was deposited (0.3 μm thick). This inlay process results in a relatively planar surface (
A device fabricated with metal resistive heaters and oxide/nitride/oxide coating was tested for biological compatibility and temperature control by using PCR amplification of a known DNA template sample. The reaction was carried out on the planar device using twenty microliters of PCR reaction mix covered with mineral oil to prevent evaporation. The reaction mixture was cycled through a standard 35-cycle PCR temperature cycling regime using the integral temperature sensors linked to a programmable controller. Since the reaction volume was significantly larger than intended for the original heater design, a polypropylene ring was cemented to the heater surface to serve as a sample containment chamber. In all test cases, the presence of amplified reaction products indicated that the silicon dioxide surface and the heater design did not inhibit the reaction. Parallel amplification experiments performed on a commercial PCR thermocycler gave similar results. A series of PCR compatibility tests indicated that the reaction on the device is very sensitive to controller settings and to the final surface material in contact with the sample (not shown).
From the above it should be evident that the present invention can be adapted for high-volume projects, such as genotyping. The microdroplet transport avoids the current inefficiencies in liquid handling and mixing of reagents. Moreover, the devices are not limited by the nature of the reactions, including biological reactions.
In this example, a test structure is fabricated (
A thermo-pneumatic microvalve is utilized in the test structure. The schematic and process flow of the microvalve is shown in
a shows a portion of a silicon substrate 10, which is a p-type (100)-oriented Si wafer of normal thickness and moderate doping (>1 cm). The preferred wafer thickness, however, is ordinarily a function of the wafer diameter. The upper surface 12 of the silicon wafer containing substrate 10 is lapped, polished and cleaned in the normal and accepted manner. Isotropic etching using reactive ion etching (RIE) forms the diaphragm corrugations 14 with photoresist as the masking material.
b shows the definition of deep boron diffusion areas 16 to form the rims, center bosses, inlet and outlet holes of the finished device.
Following this,
A second Ni channel 32 is defined by Ni and photoresist as set forth in
Lastly, a Ti/Pt heater in glass 38 is anodically bonded to the silicon substrate (
In this example, a low melting point solder was intended to be utilized in the test structure. Because a universally useful solder-sealed microvalve will be used in a gas phase microanalytical system, it is not desirable to use a high melting point (m.p.) solder (>200° C.), which might affect the gas properties. In addition, a high m.p. solder may affect other components on the device, such as integrated circuits, and increase power consumption. As a result, low melting point solder is required. Bismuth-bearing solders have the lowest m.p.'s of 47-138° C. However, when a test structure was dipped into a pool of solder belonging to this group, all the metal layers dissolved into the solution of solder. Moreover, this solder was not selective in wetting the surface of the test structure.
In light of the results of the experiment set forth in Example 7, an attempt was made with commonly available 60:40 Sn:Pb solder (m.p. 183° C.). When the test structure was dipped into a solution of this solder, the metal layers remained intact. Furthermore, these layers demonstrated excellent wettability for the solder, i.e. the solder was confined only to the areas of metals.
In this example, a device and method for blocking fluid flow in a channel is described.
This is a Divisional of application Ser. No. 11/119,539 filed on Apr. 29, 2005 now U.S. Pat. No. 8,071,056, which is a Continuation of application(s) Ser. No. 09/517,680 filed on Mar. 2, 2000, now U.S. Pat. No. 6,949,385, issued Sep. 27, 2005, which is a Continuation of U.S. patent application Ser. No. 08/888,309 filed on Jul. 3, 1997, now U.S. Pat. No. 6,048,734, issued May 2, 2000, which is a Continuation-in-Part of U.S. patent application Ser. No. 08/529,293 filed on Sep. 15, 1995, now U.S. Pat. No. 6,057,149, issued Apr. 11, 2000.
Number | Name | Date | Kind |
---|---|---|---|
1434314 | Raich | Oct 1922 | A |
1616419 | Wilson | Feb 1927 | A |
1733401 | Lovekin | Aug 1930 | A |
3528449 | Witte et al. | Sep 1970 | A |
3813316 | Chakrabarty et al. | May 1974 | A |
3985649 | Eddelman | Oct 1976 | A |
4018089 | Dzula et al. | Apr 1977 | A |
4018652 | Lanham et al. | Apr 1977 | A |
4038192 | Serur | Jul 1977 | A |
4055395 | Honkawa et al. | Oct 1977 | A |
D249706 | Adamski | Sep 1978 | S |
4139005 | Dickey | Feb 1979 | A |
D252157 | Kronish et al. | Jun 1979 | S |
D252341 | Thomas | Jul 1979 | S |
D254687 | Fadler et al. | Apr 1980 | S |
4212744 | Oota | Jul 1980 | A |
D261033 | Armbruster | Sep 1981 | S |
D261173 | Armbruster | Oct 1981 | S |
4301412 | Hill et al. | Nov 1981 | A |
4439526 | Columbus | Mar 1984 | A |
4457329 | Werley et al. | Jul 1984 | A |
4466740 | Kano et al. | Aug 1984 | A |
4504582 | Swann | Mar 1985 | A |
4522786 | Ebersole | Jun 1985 | A |
D279817 | Chen et al. | Jul 1985 | S |
4599315 | Terasaki et al. | Jul 1986 | A |
4612873 | Eberle | Sep 1986 | A |
4612959 | Costello | Sep 1986 | A |
D288478 | Carlson et al. | Feb 1987 | S |
4654127 | Baker et al. | Mar 1987 | A |
4673657 | Christian | Jun 1987 | A |
4683195 | Mullis et al. | Jul 1987 | A |
4683202 | Mullis | Jul 1987 | A |
D292735 | Lovborg | Nov 1987 | S |
4720374 | Ramachandran | Jan 1988 | A |
4798693 | Mase et al. | Jan 1989 | A |
4800022 | Leonard | Jan 1989 | A |
4841786 | Schulz | Jun 1989 | A |
D302294 | Hillman | Jul 1989 | S |
4871779 | Killat et al. | Oct 1989 | A |
4895650 | Wang | Jan 1990 | A |
4919829 | Gates et al. | Apr 1990 | A |
4919892 | Plumb | Apr 1990 | A |
4921809 | Schiff et al. | May 1990 | A |
4935342 | Seligson et al. | Jun 1990 | A |
4946562 | Guruswamy | Aug 1990 | A |
4949742 | Rando et al. | Aug 1990 | A |
D310413 | Bigler et al. | Sep 1990 | S |
4963498 | Hillman | Oct 1990 | A |
4967950 | Legg et al. | Nov 1990 | A |
4978502 | Dole et al. | Dec 1990 | A |
4978622 | Mishell et al. | Dec 1990 | A |
4989626 | Takagi et al. | Feb 1991 | A |
5001417 | Pumphrey et al. | Mar 1991 | A |
5004583 | Guruswamy et al. | Apr 1991 | A |
5048554 | Kremer | Sep 1991 | A |
5053199 | Keiser et al. | Oct 1991 | A |
5060823 | Perlman | Oct 1991 | A |
5061336 | Soane | Oct 1991 | A |
5064618 | Baker et al. | Nov 1991 | A |
5071531 | Soane | Dec 1991 | A |
5091328 | Miller | Feb 1992 | A |
D324426 | Fan et al. | Mar 1992 | S |
5096669 | Lauks et al. | Mar 1992 | A |
5126002 | Iwata et al. | Jun 1992 | A |
5126022 | Soane et al. | Jun 1992 | A |
D328135 | Fan et al. | Jul 1992 | S |
D328794 | Frenkel et al. | Aug 1992 | S |
5135627 | Soane | Aug 1992 | A |
5135872 | Pouletty et al. | Aug 1992 | A |
5147606 | Charlton et al. | Sep 1992 | A |
5160945 | Drake | Nov 1992 | A |
5169512 | Wiedenmann et al. | Dec 1992 | A |
D333522 | Gianino | Feb 1993 | S |
5186339 | Heissler | Feb 1993 | A |
5192507 | Taylor et al. | Mar 1993 | A |
5208163 | Charlton et al. | May 1993 | A |
5223226 | Wittmer et al. | Jun 1993 | A |
D338275 | Fischer et al. | Aug 1993 | S |
5250263 | Manz | Oct 1993 | A |
5252743 | Barrett et al. | Oct 1993 | A |
5256376 | Callan et al. | Oct 1993 | A |
5275787 | Yuguchi et al. | Jan 1994 | A |
5282950 | Dietze et al. | Feb 1994 | A |
5296375 | Kricka et al. | Mar 1994 | A |
5304477 | Nagoh et al. | Apr 1994 | A |
5304487 | Wilding et al. | Apr 1994 | A |
D347478 | Pinkney | May 1994 | S |
5311896 | Kaartinen et al. | May 1994 | A |
5311996 | Duffy et al. | May 1994 | A |
5316727 | Suzuki et al. | May 1994 | A |
5327038 | Culp | Jul 1994 | A |
5339486 | Persic | Aug 1994 | A |
D351475 | Gerber | Oct 1994 | S |
D351913 | Hieb et al. | Oct 1994 | S |
5364591 | Green et al. | Nov 1994 | A |
5372946 | Cusak et al. | Dec 1994 | A |
5374395 | Robinson | Dec 1994 | A |
5385709 | Wise et al. | Jan 1995 | A |
5389339 | Petschek et al. | Feb 1995 | A |
5397709 | Berndt | Mar 1995 | A |
5401465 | Smethers et al. | Mar 1995 | A |
5411708 | Moscetta et al. | May 1995 | A |
5414245 | Hackleman | May 1995 | A |
5416000 | Allen et al. | May 1995 | A |
5422271 | Chen et al. | Jun 1995 | A |
5422284 | Lau | Jun 1995 | A |
5427946 | Kricka et al. | Jun 1995 | A |
5474796 | Brennan | Dec 1995 | A |
D366116 | Biskupski | Jan 1996 | S |
5486335 | Wilding et al. | Jan 1996 | A |
5494639 | Grzegorzewski | Feb 1996 | A |
5498392 | Wilding et al. | Mar 1996 | A |
5503803 | Brown | Apr 1996 | A |
5516410 | Schneider et al. | May 1996 | A |
5519635 | Miyake et al. | May 1996 | A |
5529677 | Schneider et al. | Jun 1996 | A |
5533412 | Jerman et al. | Jul 1996 | A |
5559432 | Logue | Sep 1996 | A |
5565171 | Dovichi et al. | Oct 1996 | A |
5569364 | Hooper et al. | Oct 1996 | A |
5578270 | Reichler et al. | Nov 1996 | A |
5578818 | Kain et al. | Nov 1996 | A |
5579928 | Anukwuem | Dec 1996 | A |
5580523 | Bard | Dec 1996 | A |
5582884 | Ball et al. | Dec 1996 | A |
5585069 | Zanzucchi et al. | Dec 1996 | A |
5585089 | Queen et al. | Dec 1996 | A |
5585242 | Bouma et al. | Dec 1996 | A |
5587128 | Wilding et al. | Dec 1996 | A |
5589136 | Northrup et al. | Dec 1996 | A |
5593838 | Zanzucchi et al. | Jan 1997 | A |
5595708 | Berndt | Jan 1997 | A |
5599432 | Manz et al. | Feb 1997 | A |
5599503 | Manz et al. | Feb 1997 | A |
5599667 | Arnold et al. | Feb 1997 | A |
5601727 | Bormann et al. | Feb 1997 | A |
5603351 | Cherukuri et al. | Feb 1997 | A |
5605662 | Heller et al. | Feb 1997 | A |
D378782 | LaBarbera et al. | Apr 1997 | S |
5628890 | Carter et al. | May 1997 | A |
5630920 | Friese et al. | May 1997 | A |
5631337 | Sassi et al. | May 1997 | A |
5632876 | Zanzucchi et al. | May 1997 | A |
5632957 | Heller et al. | May 1997 | A |
5635358 | Wilding et al. | Jun 1997 | A |
5637469 | Wilding et al. | Jun 1997 | A |
5639423 | Northrup et al. | Jun 1997 | A |
5643738 | Zanzucchi et al. | Jul 1997 | A |
5646039 | Northrup et al. | Jul 1997 | A |
5647994 | Tuunanen et al. | Jul 1997 | A |
5648482 | Meyer | Jul 1997 | A |
5651839 | Rauf | Jul 1997 | A |
5652149 | Mileaf et al. | Jul 1997 | A |
D382346 | Buhler et al. | Aug 1997 | S |
D382647 | Staples et al. | Aug 1997 | S |
5667976 | Van Ness et al. | Sep 1997 | A |
5671303 | Shieh et al. | Sep 1997 | A |
5674394 | Whitmore | Oct 1997 | A |
5674742 | Northrup et al. | Oct 1997 | A |
5681484 | Zanzucchi et al. | Oct 1997 | A |
5681529 | Taguchi et al. | Oct 1997 | A |
5683657 | Mian | Nov 1997 | A |
5699157 | Parce | Dec 1997 | A |
5700637 | Southern | Dec 1997 | A |
5705813 | Apffel et al. | Jan 1998 | A |
5726026 | Wilding et al. | Mar 1998 | A |
5726404 | Brody | Mar 1998 | A |
5726944 | Pelley et al. | Mar 1998 | A |
5731212 | Gavin et al. | Mar 1998 | A |
5744366 | Kricka et al. | Apr 1998 | A |
5747666 | Willis | May 1998 | A |
5750015 | Soane et al. | May 1998 | A |
5755942 | Zanzucchi et al. | May 1998 | A |
5763262 | Wong et al. | Jun 1998 | A |
5770029 | Nelson et al. | Jun 1998 | A |
5770388 | Vorpahl | Jun 1998 | A |
5772966 | Maracas et al. | Jun 1998 | A |
5779868 | Parce et al. | Jul 1998 | A |
5787032 | Heller et al. | Jul 1998 | A |
5788814 | Sun et al. | Aug 1998 | A |
5800600 | Lima-Marques et al. | Sep 1998 | A |
5800690 | Chow et al. | Sep 1998 | A |
5804436 | Okun et al. | Sep 1998 | A |
D399959 | Prokop et al. | Oct 1998 | S |
5827481 | Bente et al. | Oct 1998 | A |
5842106 | Thaler et al. | Nov 1998 | A |
5842787 | Kopf-Sill et al. | Dec 1998 | A |
5846396 | Zanzucchi et al. | Dec 1998 | A |
5849208 | Hayes et al. | Dec 1998 | A |
5849486 | Heller et al. | Dec 1998 | A |
5849489 | Heller | Dec 1998 | A |
5849598 | Wilson et al. | Dec 1998 | A |
5852495 | Parce | Dec 1998 | A |
5856174 | Lipshutz et al. | Jan 1999 | A |
5858187 | Ramsey et al. | Jan 1999 | A |
5858188 | Soane et al. | Jan 1999 | A |
5863502 | Southgate et al. | Jan 1999 | A |
5863708 | Zanzucchi et al. | Jan 1999 | A |
5863801 | Southgate et al. | Jan 1999 | A |
5866345 | Wilding et al. | Feb 1999 | A |
5869004 | Parce et al. | Feb 1999 | A |
5869244 | Martin et al. | Feb 1999 | A |
5872010 | Karger et al. | Feb 1999 | A |
5872623 | Stabile et al. | Feb 1999 | A |
5874046 | Megerle | Feb 1999 | A |
5876675 | Kennedy | Mar 1999 | A |
5880071 | Parce et al. | Mar 1999 | A |
5882465 | McReynolds | Mar 1999 | A |
5883211 | Sassi et al. | Mar 1999 | A |
5885432 | Hooper et al. | Mar 1999 | A |
5885470 | Parce et al. | Mar 1999 | A |
5895762 | Greenfield et al. | Apr 1999 | A |
5900130 | Benregnu et al. | May 1999 | A |
5912124 | Kumar | Jun 1999 | A |
5912134 | Shartle | Jun 1999 | A |
5916522 | Boyd et al. | Jun 1999 | A |
5916776 | Kumar | Jun 1999 | A |
5919646 | Okun et al. | Jul 1999 | A |
5919711 | Boyd et al. | Jul 1999 | A |
5922591 | Anderson et al. | Jul 1999 | A |
5927547 | Papen et al. | Jul 1999 | A |
5928880 | Wilding et al. | Jul 1999 | A |
5929208 | Heller et al. | Jul 1999 | A |
D413391 | Lapeus et al. | Aug 1999 | S |
5932799 | Moles | Aug 1999 | A |
5935401 | Amigo | Aug 1999 | A |
5939291 | Loewy et al. | Aug 1999 | A |
5942443 | Parce et al. | Aug 1999 | A |
D413677 | Dumitrescu et al. | Sep 1999 | S |
5948227 | Dubrow | Sep 1999 | A |
5955028 | Chow | Sep 1999 | A |
5955029 | Wilding et al. | Sep 1999 | A |
5957579 | Kopf-Sill et al. | Sep 1999 | A |
5958203 | Parce et al. | Sep 1999 | A |
5958694 | Nikiforov | Sep 1999 | A |
5959221 | Boyd et al. | Sep 1999 | A |
5959291 | Jensen | Sep 1999 | A |
5964995 | Nikiforov et al. | Oct 1999 | A |
5964997 | McBride | Oct 1999 | A |
5965001 | Chow et al. | Oct 1999 | A |
5965410 | Chow et al. | Oct 1999 | A |
5965886 | Sauer et al. | Oct 1999 | A |
5968745 | Thorp et al. | Oct 1999 | A |
5972187 | Parce et al. | Oct 1999 | A |
5973138 | Collis | Oct 1999 | A |
D417009 | Boyd | Nov 1999 | S |
5976336 | Dubrow et al. | Nov 1999 | A |
5980704 | Cherukuri et al. | Nov 1999 | A |
5980719 | Cherukuri et al. | Nov 1999 | A |
5981735 | Thatcher et al. | Nov 1999 | A |
5989402 | Chow et al. | Nov 1999 | A |
5992820 | Fare et al. | Nov 1999 | A |
5993611 | Moroney et al. | Nov 1999 | A |
5993750 | Ghosh et al. | Nov 1999 | A |
5997708 | Craig | Dec 1999 | A |
6001229 | Ramsey | Dec 1999 | A |
6001231 | Kopf-Sill | Dec 1999 | A |
6001307 | Naka et al. | Dec 1999 | A |
6004515 | Parce et al. | Dec 1999 | A |
6007690 | Nelson et al. | Dec 1999 | A |
6010607 | Ramsey | Jan 2000 | A |
6010608 | Ramsey | Jan 2000 | A |
6010627 | Hood | Jan 2000 | A |
6012902 | Parce | Jan 2000 | A |
D420747 | Dumitrescu et al. | Feb 2000 | S |
D421130 | Cohen et al. | Feb 2000 | S |
6024920 | Cunanan | Feb 2000 | A |
D421653 | Purcell | Mar 2000 | S |
6033546 | Ramsey | Mar 2000 | A |
6043080 | Lipshutz et al. | Mar 2000 | A |
6046056 | Parce et al. | Apr 2000 | A |
6048734 | Burns et al. | Apr 2000 | A |
6054034 | Soane et al. | Apr 2000 | A |
6054277 | Furcht et al. | Apr 2000 | A |
6056860 | Amigo et al. | May 2000 | A |
6057149 | Burns et al. | May 2000 | A |
6062261 | Jacobson et al. | May 2000 | A |
6063341 | Fassbind et al. | May 2000 | A |
6063589 | Kellogg et al. | May 2000 | A |
6068752 | Dubrow et al. | May 2000 | A |
6071478 | Chow | Jun 2000 | A |
6074725 | Kennedy | Jun 2000 | A |
6074827 | Nelson et al. | Jun 2000 | A |
D428497 | Lapeus et al. | Jul 2000 | S |
6086740 | Kennedy | Jul 2000 | A |
6096509 | Okun et al. | Aug 2000 | A |
6100541 | Nagle et al. | Aug 2000 | A |
6102897 | Lang | Aug 2000 | A |
6103537 | Ullman et al. | Aug 2000 | A |
6106685 | McBride et al. | Aug 2000 | A |
6110343 | Ramsey et al. | Aug 2000 | A |
6123205 | Dumitrescu et al. | Sep 2000 | A |
6123798 | Gandhi et al. | Sep 2000 | A |
6130098 | Handique et al. | Oct 2000 | A |
6132580 | Mathies et al. | Oct 2000 | A |
6132684 | Marino | Oct 2000 | A |
6133436 | Koster et al. | Oct 2000 | A |
D433759 | Mathis et al. | Nov 2000 | S |
6143250 | Tajima | Nov 2000 | A |
6149787 | Chow et al. | Nov 2000 | A |
6156199 | Zuk | Dec 2000 | A |
6158269 | Dorenkott et al. | Dec 2000 | A |
6167910 | Chow | Jan 2001 | B1 |
6168948 | Anderson et al. | Jan 2001 | B1 |
6171850 | Nagle et al. | Jan 2001 | B1 |
6174675 | Chow et al. | Jan 2001 | B1 |
6180950 | Olsen | Jan 2001 | B1 |
D438311 | Yamanishi et al. | Feb 2001 | S |
6190619 | Kilcoin et al. | Feb 2001 | B1 |
D438632 | Miller | Mar 2001 | S |
D438633 | Miller | Mar 2001 | S |
6197595 | Anderson et al. | Mar 2001 | B1 |
6211989 | Wulf et al. | Apr 2001 | B1 |
6213151 | Jacobson et al. | Apr 2001 | B1 |
6221600 | MacLeod et al. | Apr 2001 | B1 |
6228635 | Armstrong et al. | May 2001 | B1 |
6232072 | Fisher | May 2001 | B1 |
6235175 | Dubrow et al. | May 2001 | B1 |
6235313 | Mathiowitz et al. | May 2001 | B1 |
6235471 | Knapp et al. | May 2001 | B1 |
6236456 | Giebeler et al. | May 2001 | B1 |
6236581 | Foss et al. | May 2001 | B1 |
6251343 | Dubrow et al. | Jun 2001 | B1 |
6254826 | Acosta et al. | Jul 2001 | B1 |
6259635 | Khouri et al. | Jul 2001 | B1 |
6261431 | Mathies et al. | Jul 2001 | B1 |
6267858 | Parce et al. | Jul 2001 | B1 |
D446306 | Ochi et al. | Aug 2001 | S |
6271021 | Burns et al. | Aug 2001 | B1 |
6274089 | Chow et al. | Aug 2001 | B1 |
6280967 | Ransom et al. | Aug 2001 | B1 |
6281008 | Komai et al. | Aug 2001 | B1 |
6284113 | Bjornson et al. | Sep 2001 | B1 |
6287254 | Dodds | Sep 2001 | B1 |
6287774 | Kikiforov | Sep 2001 | B1 |
6291248 | Haj-Ahmad | Sep 2001 | B1 |
6294063 | Becker et al. | Sep 2001 | B1 |
6302134 | Kellogg et al. | Oct 2001 | B1 |
6302304 | Spencer | Oct 2001 | B1 |
6303343 | Kopf-Sill | Oct 2001 | B1 |
6306273 | Wainright et al. | Oct 2001 | B1 |
6306590 | Mehta et al. | Oct 2001 | B1 |
6319469 | Mian et al. | Nov 2001 | B1 |
6322683 | Wolk et al. | Nov 2001 | B1 |
6326083 | Yang et al. | Dec 2001 | B1 |
6326211 | Anderson et al. | Dec 2001 | B1 |
6334980 | Hayes et al. | Jan 2002 | B1 |
6337435 | Chu et al. | Jan 2002 | B1 |
6353475 | Jensen et al. | Mar 2002 | B1 |
6358387 | Kopf-Sill et al. | Mar 2002 | B1 |
6366924 | Parce | Apr 2002 | B1 |
6368871 | Christel et al. | Apr 2002 | B1 |
6370206 | Schenk | Apr 2002 | B1 |
6375185 | Lin | Apr 2002 | B1 |
6375901 | Robotti et al. | Apr 2002 | B1 |
6379884 | Wada et al. | Apr 2002 | B2 |
6379929 | Burns et al. | Apr 2002 | B1 |
6379974 | Parce et al. | Apr 2002 | B1 |
6382254 | Yang et al. | May 2002 | B1 |
6391541 | Petersen et al. | May 2002 | B1 |
6391623 | Besemer et al. | May 2002 | B1 |
6395161 | Schneider et al. | May 2002 | B1 |
6398956 | Coville et al. | Jun 2002 | B1 |
6399025 | Chow | Jun 2002 | B1 |
6399389 | Parce et al. | Jun 2002 | B1 |
6399952 | Maher et al. | Jun 2002 | B1 |
6401552 | Elkins | Jun 2002 | B1 |
6403338 | Knapp et al. | Jun 2002 | B1 |
6408878 | Unger et al. | Jun 2002 | B2 |
6413401 | Chow et al. | Jul 2002 | B1 |
6416642 | Alajoki et al. | Jul 2002 | B1 |
6420143 | Kopf-Sill | Jul 2002 | B1 |
6425972 | McReynolds | Jul 2002 | B1 |
D461906 | Pham | Aug 2002 | S |
6428987 | Franzen | Aug 2002 | B2 |
6430512 | Gallagher | Aug 2002 | B1 |
6432366 | Ruediger et al. | Aug 2002 | B2 |
6440725 | Pourahmadi et al. | Aug 2002 | B1 |
D463031 | Slomski et al. | Sep 2002 | S |
6444461 | Knapp et al. | Sep 2002 | B1 |
6447661 | Chow et al. | Sep 2002 | B1 |
6447727 | Parce et al. | Sep 2002 | B1 |
6448064 | Vo-Dinh et al. | Sep 2002 | B1 |
6453928 | Kaplan et al. | Sep 2002 | B1 |
6465257 | Parce et al. | Oct 2002 | B1 |
6468761 | Yang et al. | Oct 2002 | B2 |
6472141 | Nikiforov | Oct 2002 | B2 |
6475364 | Dubrow et al. | Nov 2002 | B1 |
D467348 | McMichael et al. | Dec 2002 | S |
D467349 | Niedbala et al. | Dec 2002 | S |
6488897 | Dubrow et al. | Dec 2002 | B2 |
6495104 | Unno et al. | Dec 2002 | B1 |
6498497 | Chow et al. | Dec 2002 | B1 |
6500323 | Chow et al. | Dec 2002 | B1 |
6500390 | Boulton et al. | Dec 2002 | B1 |
D468437 | McMenamy et al. | Jan 2003 | S |
6506609 | Wada et al. | Jan 2003 | B1 |
6509193 | Tajima | Jan 2003 | B1 |
6511853 | Kopf-Sill et al. | Jan 2003 | B1 |
D470595 | Crisanti et al. | Feb 2003 | S |
6515753 | Maher | Feb 2003 | B2 |
6517783 | Horner et al. | Feb 2003 | B2 |
6520197 | Deshmukh et al. | Feb 2003 | B2 |
6521188 | Webster | Feb 2003 | B1 |
6524456 | Ramsey et al. | Feb 2003 | B1 |
6524790 | Kopf-Sill et al. | Feb 2003 | B1 |
D472324 | Rumore et al. | Mar 2003 | S |
6534295 | Tai et al. | Mar 2003 | B2 |
6537771 | Farinas et al. | Mar 2003 | B1 |
6540896 | Manz et al. | Apr 2003 | B1 |
6544734 | Briscoe et al. | Apr 2003 | B1 |
6547942 | Parce et al. | Apr 2003 | B1 |
6555389 | Ullman et al. | Apr 2003 | B1 |
6556923 | Gallagher et al. | Apr 2003 | B2 |
D474279 | Mayer et al. | May 2003 | S |
D474280 | Niedbala et al. | May 2003 | S |
6558916 | Veerapandian et al. | May 2003 | B2 |
6558945 | Kao | May 2003 | B1 |
6569607 | McReynolds | May 2003 | B2 |
6572830 | Burdon et al. | Jun 2003 | B1 |
6575188 | Parunak | Jun 2003 | B2 |
6576459 | Miles et al. | Jun 2003 | B2 |
6579453 | Bächler et al. | Jun 2003 | B1 |
6589729 | Chan et al. | Jul 2003 | B2 |
6592821 | Wada et al. | Jul 2003 | B1 |
6597450 | Andrews et al. | Jul 2003 | B1 |
6602474 | Tajima | Aug 2003 | B1 |
6613211 | McCormick et al. | Sep 2003 | B1 |
6613512 | Kopf-sill et al. | Sep 2003 | B1 |
6613580 | Chow et al. | Sep 2003 | B1 |
6613581 | Wada et al. | Sep 2003 | B1 |
6614030 | Maher et al. | Sep 2003 | B2 |
6620625 | Wolk et al. | Sep 2003 | B2 |
6623860 | Hu et al. | Sep 2003 | B2 |
6627406 | Singh et al. | Sep 2003 | B1 |
D480814 | Lafferty et al. | Oct 2003 | S |
6632655 | Mehta et al. | Oct 2003 | B1 |
6633785 | Kasahara et al. | Oct 2003 | B1 |
D482796 | Oyama et al. | Nov 2003 | S |
6649358 | Parce et al. | Nov 2003 | B1 |
6664104 | Pourahmadi et al. | Dec 2003 | B2 |
6669831 | Chow et al. | Dec 2003 | B2 |
6670153 | Stern | Dec 2003 | B2 |
D484989 | Gebrian | Jan 2004 | S |
6681616 | Spaid et al. | Jan 2004 | B2 |
6681788 | Parce et al. | Jan 2004 | B2 |
6685813 | Williams et al. | Feb 2004 | B2 |
6692700 | Handique | Feb 2004 | B2 |
6695009 | Chien et al. | Feb 2004 | B2 |
6706519 | Kellogg et al. | Mar 2004 | B1 |
6720148 | Nikiforov | Apr 2004 | B1 |
6730206 | Ricco et al. | May 2004 | B2 |
6733645 | Chow | May 2004 | B1 |
6734401 | Bedingham et al. | May 2004 | B2 |
6737026 | Bergh et al. | May 2004 | B1 |
6740518 | Duong et al. | May 2004 | B1 |
D491272 | Alden et al. | Jun 2004 | S |
D491273 | Biegler et al. | Jun 2004 | S |
D491276 | Langille | Jun 2004 | S |
6750661 | Brooks et al. | Jun 2004 | B2 |
6752966 | Chazan | Jun 2004 | B1 |
6756019 | Dubrow et al. | Jun 2004 | B1 |
6766817 | da Silva | Jul 2004 | B2 |
6773567 | Wolk | Aug 2004 | B1 |
6777184 | Nikiforov et al. | Aug 2004 | B2 |
6783962 | Olander et al. | Aug 2004 | B1 |
D495805 | Lea et al. | Sep 2004 | S |
6787015 | Lackritz et al. | Sep 2004 | B2 |
6787016 | Tan et al. | Sep 2004 | B2 |
6790328 | Jacobson et al. | Sep 2004 | B2 |
6790330 | Gascoyne et al. | Sep 2004 | B2 |
6811668 | Berndt et al. | Nov 2004 | B1 |
6818113 | Williams et al. | Nov 2004 | B2 |
6819027 | Saraf | Nov 2004 | B2 |
6824663 | Boone | Nov 2004 | B1 |
D499813 | Wu | Dec 2004 | S |
D500142 | Crisanti et al. | Dec 2004 | S |
6827831 | Chow et al. | Dec 2004 | B1 |
6827906 | Bjornson et al. | Dec 2004 | B1 |
6838156 | Neyer et al. | Jan 2005 | B1 |
6838680 | Maher et al. | Jan 2005 | B2 |
6852287 | Ganesan | Feb 2005 | B2 |
6858185 | Kopf-sill et al. | Feb 2005 | B1 |
6859698 | Schmeisser | Feb 2005 | B2 |
6861035 | Pham et al. | Mar 2005 | B2 |
6878540 | Pourahmadi et al. | Apr 2005 | B2 |
6878755 | Singh et al. | Apr 2005 | B2 |
6884628 | Hubbell et al. | Apr 2005 | B2 |
6887693 | McMillan et al. | May 2005 | B2 |
6893879 | Petersen et al. | May 2005 | B2 |
6900889 | Bjornson et al. | May 2005 | B2 |
6905583 | Wainright et al. | Jun 2005 | B2 |
6905612 | Dorian et al. | Jun 2005 | B2 |
6906797 | Kao et al. | Jun 2005 | B1 |
6908594 | Schaevitz et al. | Jun 2005 | B1 |
6911183 | Handique et al. | Jun 2005 | B1 |
6914137 | Baker | Jul 2005 | B2 |
6915679 | Chien et al. | Jul 2005 | B2 |
6918404 | Dias da Silva | Jul 2005 | B2 |
D508999 | Fanning et al. | Aug 2005 | S |
6939451 | Zhao et al. | Sep 2005 | B2 |
6942771 | Kayyem | Sep 2005 | B1 |
6958392 | Fomovskaia et al. | Oct 2005 | B2 |
D512155 | Matsumoto | Nov 2005 | S |
6964747 | Banerjee et al. | Nov 2005 | B2 |
6977163 | Mehta | Dec 2005 | B1 |
6984516 | Briscoe et al. | Jan 2006 | B2 |
D515707 | Shinohara et al. | Feb 2006 | S |
D516221 | Wohlstadter et al. | Feb 2006 | S |
7001853 | Brown et al. | Feb 2006 | B1 |
7004184 | Handique et al. | Feb 2006 | B2 |
D517554 | Yanagisawa et al. | Mar 2006 | S |
7010391 | Handique et al. | Mar 2006 | B2 |
7023007 | Gallagher | Apr 2006 | B2 |
7024281 | Unno | Apr 2006 | B1 |
7036667 | Greenstein et al. | May 2006 | B2 |
7037416 | Parce et al. | May 2006 | B2 |
7038472 | Chien | May 2006 | B1 |
7039527 | Tripathi et al. | May 2006 | B2 |
7040144 | Spaid et al. | May 2006 | B2 |
D523153 | Akashi et al. | Jun 2006 | S |
7055695 | Greenstein et al. | Jun 2006 | B2 |
7060171 | Nikiforov et al. | Jun 2006 | B1 |
7066586 | da Silva | Jun 2006 | B2 |
7069952 | McReynolds et al. | Jul 2006 | B1 |
7099778 | Chien | Aug 2006 | B2 |
D528215 | Malmsater | Sep 2006 | S |
7101467 | Spaid | Sep 2006 | B2 |
7105304 | Nikiforov et al. | Sep 2006 | B1 |
D531321 | Godfrey et al. | Oct 2006 | S |
7118910 | Unger et al. | Oct 2006 | B2 |
7138032 | Gandhi et al. | Nov 2006 | B2 |
D534280 | Gomm et al. | Dec 2006 | S |
7148043 | Kordunsky et al. | Dec 2006 | B2 |
7150814 | Parce et al. | Dec 2006 | B1 |
7150999 | Shuck | Dec 2006 | B1 |
D535403 | Isozaki et al. | Jan 2007 | S |
7160423 | Chien et al. | Jan 2007 | B2 |
7161356 | Chien | Jan 2007 | B1 |
7169277 | Ausserer et al. | Jan 2007 | B2 |
7169618 | Skold | Jan 2007 | B2 |
D537951 | Okamoto et al. | Mar 2007 | S |
D538436 | Patadia et al. | Mar 2007 | S |
7192557 | Wu et al. | Mar 2007 | B2 |
7195036 | Burns et al. | Mar 2007 | B2 |
7195986 | Bousse et al. | Mar 2007 | B1 |
7208125 | Dong | Apr 2007 | B1 |
7235406 | Woudenberg et al. | Jun 2007 | B1 |
7247274 | Chow | Jul 2007 | B1 |
D548841 | Brownell et al. | Aug 2007 | S |
D549827 | Maeno et al. | Aug 2007 | S |
7252928 | Hafeman et al. | Aug 2007 | B1 |
7270786 | Parunak et al. | Sep 2007 | B2 |
D554069 | Bolotin et al. | Oct 2007 | S |
D554070 | Bolotin et al. | Oct 2007 | S |
7276330 | Chow et al. | Oct 2007 | B2 |
D556914 | Okamoto et al. | Dec 2007 | S |
7303727 | Dubrow et al. | Dec 2007 | B1 |
D559995 | Handique et al. | Jan 2008 | S |
7323140 | Handique et al. | Jan 2008 | B2 |
7332130 | Handique | Feb 2008 | B2 |
7338760 | Gong et al. | Mar 2008 | B2 |
D566291 | Parunak et al. | Apr 2008 | S |
7351377 | Chazan et al. | Apr 2008 | B2 |
D569526 | Duffy et al. | May 2008 | S |
7374949 | Kuriger | May 2008 | B2 |
7390460 | Osawa et al. | Jun 2008 | B2 |
7419784 | Dubrow et al. | Sep 2008 | B2 |
7422669 | Jacobson et al. | Sep 2008 | B2 |
7440684 | Spaid et al. | Oct 2008 | B2 |
7476313 | Siddiqi | Jan 2009 | B2 |
7494577 | Williams et al. | Feb 2009 | B2 |
7494770 | Wilding et al. | Feb 2009 | B2 |
7514046 | Kechagia et al. | Apr 2009 | B2 |
7518726 | Rulison et al. | Apr 2009 | B2 |
7521186 | Burd | Apr 2009 | B2 |
7527769 | Bunch et al. | May 2009 | B2 |
D595423 | Johansson et al. | Jun 2009 | S |
7553671 | Sinclair et al. | Jun 2009 | B2 |
D596312 | Giraud et al. | Jul 2009 | S |
D598566 | Allaer | Aug 2009 | S |
D599234 | Ito | Sep 2009 | S |
7595197 | Brasseur | Sep 2009 | B2 |
7604938 | Takahashi et al. | Oct 2009 | B2 |
7635588 | King et al. | Dec 2009 | B2 |
7645581 | Knapp et al. | Jan 2010 | B2 |
7670559 | Chien et al. | Mar 2010 | B2 |
7674431 | Ganesan | Mar 2010 | B2 |
7704735 | Facer et al. | Apr 2010 | B2 |
7723123 | Murphy et al. | May 2010 | B1 |
D618820 | Wilson et al. | Jun 2010 | S |
7727371 | Kennedy et al. | Jun 2010 | B2 |
7727477 | Boronkay et al. | Jun 2010 | B2 |
7744817 | Bui | Jun 2010 | B2 |
D621060 | Handique | Aug 2010 | S |
7867776 | Kennedy et al. | Jan 2011 | B2 |
D632799 | Canner et al. | Feb 2011 | S |
7892819 | Wilding et al. | Feb 2011 | B2 |
7998708 | Handique et al. | Aug 2011 | B2 |
8088616 | Handique | Jan 2012 | B2 |
8105783 | Handique | Jan 2012 | B2 |
8133671 | Williams et al. | Mar 2012 | B2 |
8182763 | Duffy et al. | May 2012 | B2 |
8287820 | Williams et al. | Oct 2012 | B2 |
8323584 | Ganesan | Dec 2012 | B2 |
8323900 | Handique et al. | Dec 2012 | B2 |
8324372 | Brahmasandra et al. | Dec 2012 | B2 |
20010023848 | Gjerde et al. | Sep 2001 | A1 |
20010038450 | McCaffrey et al. | Nov 2001 | A1 |
20010046702 | Schembri | Nov 2001 | A1 |
20010055765 | O'Keefe et al. | Dec 2001 | A1 |
20020001848 | Bedingham et al. | Jan 2002 | A1 |
20020008053 | Hansen et al. | Jan 2002 | A1 |
20020009015 | Laugharn et al. | Jan 2002 | A1 |
20020015667 | Chow | Feb 2002 | A1 |
20020021983 | Comte et al. | Feb 2002 | A1 |
20020037499 | Quake et al. | Mar 2002 | A1 |
20020039783 | McMillan et al. | Apr 2002 | A1 |
20020053399 | Soane et al. | May 2002 | A1 |
20020054835 | Robotti et al. | May 2002 | A1 |
20020055167 | Pourahmadi et al. | May 2002 | A1 |
20020058332 | Quake et al. | May 2002 | A1 |
20020060156 | Mathies et al. | May 2002 | A1 |
20020068357 | Mathies et al. | Jun 2002 | A1 |
20020141903 | Parunak et al. | Oct 2002 | A1 |
20020142471 | Handique et al. | Oct 2002 | A1 |
20020143297 | Francavilla et al. | Oct 2002 | A1 |
20020143437 | Handique et al. | Oct 2002 | A1 |
20020155477 | Ito | Oct 2002 | A1 |
20020169518 | Luoma et al. | Nov 2002 | A1 |
20020187557 | Hobbs et al. | Dec 2002 | A1 |
20030019522 | Parunak | Jan 2003 | A1 |
20030049833 | Chen et al. | Mar 2003 | A1 |
20030064507 | Gallagher et al. | Apr 2003 | A1 |
20030070677 | Handique et al. | Apr 2003 | A1 |
20030073106 | Johansen et al. | Apr 2003 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030087300 | Knapp et al. | May 2003 | A1 |
20030127327 | Kurnik | Jul 2003 | A1 |
20030136679 | Bohn et al. | Jul 2003 | A1 |
20030186295 | Colin et al. | Oct 2003 | A1 |
20030199081 | Wilding et al. | Oct 2003 | A1 |
20030211517 | Carulli et al. | Nov 2003 | A1 |
20040014238 | Krug et al. | Jan 2004 | A1 |
20040029258 | Heaney et al. | Feb 2004 | A1 |
20040029260 | Hansen et al. | Feb 2004 | A1 |
20040037739 | McNeely et al. | Feb 2004 | A1 |
20040053290 | Terbrueggen et al. | Mar 2004 | A1 |
20040063217 | Webster et al. | Apr 2004 | A1 |
20040072278 | Chou et al. | Apr 2004 | A1 |
20040072375 | Gjerde et al. | Apr 2004 | A1 |
20040086956 | Bachur | May 2004 | A1 |
20040141887 | Mainquist et al. | Jul 2004 | A1 |
20040151629 | Pease et al. | Aug 2004 | A1 |
20040157220 | Kurnool et al. | Aug 2004 | A1 |
20040161788 | Chen et al. | Aug 2004 | A1 |
20040189311 | Glezer et al. | Sep 2004 | A1 |
20040200909 | McMillan et al. | Oct 2004 | A1 |
20040209331 | Ririe | Oct 2004 | A1 |
20040209354 | Mathies et al. | Oct 2004 | A1 |
20040219070 | Handique | Nov 2004 | A1 |
20040240097 | Evans | Dec 2004 | A1 |
20050009174 | Nikiforov et al. | Jan 2005 | A1 |
20050041525 | Pugia et al. | Feb 2005 | A1 |
20050048540 | Inami et al. | Mar 2005 | A1 |
20050058574 | Bysouth et al. | Mar 2005 | A1 |
20050084424 | Ganesan et al. | Apr 2005 | A1 |
20050106066 | Saltsman et al. | May 2005 | A1 |
20050121324 | Park et al. | Jun 2005 | A1 |
20050133370 | Park et al. | Jun 2005 | A1 |
20050135655 | Kopf-Sill et al. | Jun 2005 | A1 |
20050152808 | Ganesan | Jul 2005 | A1 |
20050170362 | Wada et al. | Aug 2005 | A1 |
20050186585 | Juncosa et al. | Aug 2005 | A1 |
20050202470 | Sundberg et al. | Sep 2005 | A1 |
20050202504 | Anderson et al. | Sep 2005 | A1 |
20050208676 | Kahatt | Sep 2005 | A1 |
20050220675 | Reed et al. | Oct 2005 | A1 |
20050227269 | Lloyd et al. | Oct 2005 | A1 |
20050233370 | Ammann et al. | Oct 2005 | A1 |
20050238545 | Parce et al. | Oct 2005 | A1 |
20050272079 | Burns et al. | Dec 2005 | A1 |
20060041058 | Yin et al. | Feb 2006 | A1 |
20060057039 | Morse et al. | Mar 2006 | A1 |
20060057629 | Kim | Mar 2006 | A1 |
20060062696 | Chow et al. | Mar 2006 | A1 |
20060094108 | Yoder et al. | May 2006 | A1 |
20060113190 | Kurnik | Jun 2006 | A1 |
20060133965 | Tajima et al. | Jun 2006 | A1 |
20060134790 | Tanaka et al. | Jun 2006 | A1 |
20060148063 | Fauzzi et al. | Jul 2006 | A1 |
20060165558 | Witty et al. | Jul 2006 | A1 |
20060165559 | Greenstein et al. | Jul 2006 | A1 |
20060166233 | Wu et al. | Jul 2006 | A1 |
20060177376 | Tomalia et al. | Aug 2006 | A1 |
20060177855 | Utermohlen et al. | Aug 2006 | A1 |
20060183216 | Handique | Aug 2006 | A1 |
20060207944 | Siddiqi | Sep 2006 | A1 |
20060246493 | Jensen et al. | Nov 2006 | A1 |
20060246533 | Fathollahi et al. | Nov 2006 | A1 |
20070004028 | Lair et al. | Jan 2007 | A1 |
20070009386 | Padmanabhan et al. | Jan 2007 | A1 |
20070020699 | Carpenter et al. | Jan 2007 | A1 |
20070026421 | Sundberg et al. | Feb 2007 | A1 |
20070042441 | Masters et al. | Feb 2007 | A1 |
20070092901 | Ligler et al. | Apr 2007 | A1 |
20070098600 | Kayyem et al. | May 2007 | A1 |
20070099200 | Chow et al. | May 2007 | A1 |
20070104617 | Coulling et al. | May 2007 | A1 |
20070154895 | Spaid et al. | Jul 2007 | A1 |
20070177147 | Parce | Aug 2007 | A1 |
20070178607 | Prober et al. | Aug 2007 | A1 |
20070184463 | Molho et al. | Aug 2007 | A1 |
20070184547 | Handique et al. | Aug 2007 | A1 |
20070196238 | Kennedy et al. | Aug 2007 | A1 |
20070199821 | Chow | Aug 2007 | A1 |
20070215554 | Kreuwel et al. | Sep 2007 | A1 |
20070218459 | Miller et al. | Sep 2007 | A1 |
20070231213 | Prabhu et al. | Oct 2007 | A1 |
20070261479 | Spaid et al. | Nov 2007 | A1 |
20070269861 | Williams et al. | Nov 2007 | A1 |
20070292941 | Handique et al. | Dec 2007 | A1 |
20080000774 | Park et al. | Jan 2008 | A1 |
20080050804 | Handique et al. | Feb 2008 | A1 |
20080056948 | Dale et al. | Mar 2008 | A1 |
20080075634 | Herchenbach et al. | Mar 2008 | A1 |
20080090244 | Knapp et al. | Apr 2008 | A1 |
20080095673 | Xu | Apr 2008 | A1 |
20080118987 | Eastwood et al. | May 2008 | A1 |
20080124723 | Dale et al. | May 2008 | A1 |
20080149840 | Handique et al. | Jun 2008 | A1 |
20080160601 | Handique | Jul 2008 | A1 |
20080182301 | Handique et al. | Jul 2008 | A1 |
20080192254 | Kim et al. | Aug 2008 | A1 |
20080247914 | Edens et al. | Oct 2008 | A1 |
20080262213 | Wu et al. | Oct 2008 | A1 |
20090047713 | Handique | Feb 2009 | A1 |
20090129978 | Wilson et al. | May 2009 | A1 |
20090130719 | Handique | May 2009 | A1 |
20090130745 | Williams et al. | May 2009 | A1 |
20090131650 | Brahmasandra et al. | May 2009 | A1 |
20090134069 | Handique | May 2009 | A1 |
20090136385 | Handique et al. | May 2009 | A1 |
20090136386 | Duffy et al. | May 2009 | A1 |
20090155123 | Williams et al. | Jun 2009 | A1 |
20090189089 | Bedingham et al. | Jul 2009 | A1 |
20090221059 | Williams et al. | Sep 2009 | A1 |
20090223925 | Morse et al. | Sep 2009 | A1 |
20100009351 | Brahmasandra et al. | Jan 2010 | A1 |
20100173393 | Handique et al. | Jul 2010 | A1 |
20110020876 | Wilding et al. | Jan 2011 | A1 |
20110027151 | Handique et al. | Feb 2011 | A1 |
20110207140 | Handique et al. | Aug 2011 | A1 |
20110210257 | Handique et al. | Sep 2011 | A9 |
20120022695 | Handique et al. | Jan 2012 | A1 |
20120085416 | Ganesan | Apr 2012 | A1 |
20120122108 | Handique | May 2012 | A1 |
20120160826 | Handique | Jun 2012 | A1 |
20120171759 | Williams et al. | Jul 2012 | A1 |
20120183454 | Handique | Jul 2012 | A1 |
20120258463 | Duffy et al. | Oct 2012 | A1 |
Number | Date | Country |
---|---|---|
2294819 | Jan 1999 | CA |
19929734 | Dec 1999 | DE |
0766256 | Apr 1997 | EP |
1745153 | Jan 2007 | EP |
2672301 | Jul 1992 | FR |
2672301 | Aug 1992 | FR |
2795426 | Dec 2000 | FR |
58212921 | Dec 1983 | JP |
58212921 | Dec 1983 | JP |
H07-290706 | Nov 1995 | JP |
2001-502790 | Jan 1998 | JP |
2000-514928 | Apr 1999 | JP |
2001-509437 | Jul 2001 | JP |
2001-515216 | Sep 2001 | JP |
2001-527220 | Dec 2001 | JP |
2002-215241 | Jul 2002 | JP |
2003-500674 | Jan 2003 | JP |
2005-514718 | May 2005 | JP |
2005-204661 | Aug 2005 | JP |
2005-291954 | Oct 2005 | JP |
WO 8806633 | Sep 1988 | WO |
WO 9012350 | Oct 1990 | WO |
WO 9205443 | Apr 1992 | WO |
WO 9705492 | Feb 1997 | WO |
WO 9800231 | Jan 1998 | WO |
WO 9822625 | May 1998 | WO |
WO 9853311 | Nov 1998 | WO |
WO 9901688 | Jan 1999 | WO |
WO 9909042 | Feb 1999 | WO |
WO 9912016 | Mar 1999 | WO |
WO 9933559 | Jul 1999 | WO |
WO 0105510 | Jan 2001 | WO |
WO 0114931 | Mar 2001 | WO |
WO 0127614 | Apr 2001 | WO |
WO 0128684 | Apr 2001 | WO |
WO 0141931 | Jun 2001 | WO |
WO 0154813 | Aug 2001 | WO |
WO 0189681 | Nov 2001 | WO |
WO 02072264 | Sep 2002 | WO |
WO 02078845 | Oct 2002 | WO |
WO 03012325 | Feb 2003 | WO |
WO 03012406 | Feb 2003 | WO |
WO 03048295 | Jun 2003 | WO |
WO 03055605 | Jul 2003 | WO |
WO 2004007081 | Jan 2004 | WO |
WO 2004074848 | Sep 2004 | WO |
WO 2005011867 | Feb 2005 | WO |
WO 2005108620 | Nov 2005 | WO |
WO 2006079082 | Jul 2006 | WO |
WO 2007050327 | May 2007 | WO |
WO 2008030914 | Mar 2008 | WO |
WO 2008060604 | May 2008 | WO |
WO 2009012185 | Jan 2009 | WO |
WO 2010118541 | Oct 2010 | WO |
Entry |
---|
Marmur and Lane “Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Biological Studies”, Proc.Nat.Acad.Sci, U.S.A. 46:453-461 (1960). |
Doty et et., “Strand Separation and Specific Recombination in Deoxyribonucleic Acids:Physical Chemical Studies”, Proc.Nat.Acad.Sci., U.S.A. 46:461-477 (1960). |
Hayashi et al.,“Restriction of in Vivo Genetic Transcription to one of the Complementary Strands of DNA”, Proc.Nat.Acad.Sci., U.S.A. 50:664-6671 (1963). |
Smith and Wilcox, “A Restriction Enzyme from Hemophilia influenzae”, J.Mol.Biol. 51:379-391 (1970). |
Southern, “Detection of Specific Sequences Among DNA Fragments Separated by Gel Electrophoresis”, J.Mol.Biol. 98:503-517 (1975). |
Maxam and Gilbert, “A new method for sequencing DNA”, Proc. Natl. Acad Sci. USA 74:560-564(1977). |
Sanger et al., “DNA sequencing with chain-terminating inhibitors”, Proc. Natl. Acad Sci. USA 74:5463-5467 (1977). |
Chen and Seeburg, “Laboratory Methods Supercoil Sequencing: A Fast and Simple Method for Sequencing Plasmid DNA”, DNA 4(2):165-170 (1985). |
Graham et al., “Direct DNA sequencing using avian myeloblastosis virus and Moleney murine leukemia virus reverse transcriptase”, Bethesda Res. Lab. Focus 8(2):;4 (1986). |
Sambrook, J. et al., Molecular Cloning, A Laboratory Manual, 2d Ed. Cold Spring Harbor Laboratory Press, New York, 13.7-13.9. |
Hunkapiller, M.W., “Advances in DNA sequencing technology”, Curr. Op. Gen. Devl. 1:88-92 (1991). |
Tabor et al., “DNA sequence analysis with a modified bacteriophage T7 DNA polymerase”, Proc. Natl. Acad. Sci. USA 84:4767-4771 (1987). |
Innis et al., “DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA”, Proc. Natl. Acad. Sci. USA 85:9436-9440 (1988). |
J. Pfahler et al.,“Liquid Transport in Micron and Submicron Channels”, Sensors and Actuators A21-A23: 431-434 (1990). |
H.T.G. Van Lintel et at., “A Piezoelectric Micropump Based on Micromachining of Silicon”, Sensors and Actuators 15:153-167 (1988). |
Smits, “Piezoelectric Micropump with Three Valves Working Peristaltically,” Sensors and Actuators A21-A23:203-206 (1990). |
Mullis and Faloona, “Specific Synthesis of DNA in Vitro via a Polymerase-Catalyzed Chain Reaction,” Meth. Enzym. 155:335-350 (1987). |
Amheim, “Polymerase Chain Reaction Strategy,” Annu. Rev. Biochem. 61:131-156 (1992). |
Nickerson et al., “Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay,” Proc. Nat. Acad. Sci. USA 87:8923-8927 (1990). |
Gordon et al., “Capillary Electrophoresis,” Science 27:224-228 (1988). |
Lawrence Berkeley Lab Presentation, Park City, Utah (1993). |
Turner, “New Dimensions in Capillary Electrophoresis Columns,” LC-GC vol. 9 (1991). |
Heller and Tullis, “Microelectrophoresis for the separation of DNA fragments,” Electrophoresis 13:512-520 (1992). |
Manz et al., “Planar chips technology for miniaturization and integration of separation techniques into monitoring systems Capillary electrophoresis on a chip,”J. Chrom. 593:253-258 (1992). |
Jorgenson and Lukacs, “High-Resolution Separations Based on Electrophoresis and Electroosmosis,” J. Chrom. 218:209-216 (1981). |
Chamberlain et al., “BRCA1 Maps Proximal to D17S579 on Chromosome 17q21 by Genetic Analysis,” Am. J. Hum. Genet. 52:792-798 (1993). |
Ansorge et el., “High-throughput automated DNA sequencing facility with fluorescent labels at the European Molecular Biology Laboratory,” Electrophoresis 13:616-619 (1992). |
Pentoney et al., “A single-fluor approach to DNA sequence determination using high performance capillary electrophoresis,” Electrophoresis 13:467-474 (1992). |
Tenan et al., “Friction in Capillary Systems,” Journal of Applied Physics 53:6687-6692 (1982). |
Dussan, “On the Spreading of Liquids on Solid Surfaces Static and Dynamic Contact Lines,” Annual Review of Fluid Mechanics 11:371-400 (1979). |
Probstein, “Physicochemical Hydrodynamics,” (1989). |
R.F. Service, “The Incredible Shrinking Laboratory,” Science 268:26-27 (1995). |
Presentation at Cold Spring Harbor (Aug. 31-Sep. 2, 1995). |
R. Nowak, “Xeroxing DNA Analysis” Science 268:1135 (1995). |
Manz, A. et al., “Electroosmotic pumping and electrophoretic separations for miniaturized chemical analysis systems” J. Microntech. Microeng. 4:257-265 (1994). |
Wooley and Mathies, “Ultra-High-Speed DNA Sequencing Using Capillary Electrophoresis Chips,” Anal. Chem.67:3676-3680 (1995). |
Effenhauser et al., “Manipulation of Sample Fractions on a Capillary Electrophoresis Chip,” Anal. Chem. 67:2284-2287 (1995). |
Van der Moolen, J.N. et al., “A Micromachined Injection Device for CZE: Application to Correlation CZE” Anal. Chem., 69:4220-4225 (1997). |
P.B. Hieptas et al., “Ultrathin Slab Gel Separations of DNA Using Single Capillary Sample Introduction System,” Anal. Chem. 69:2292-2298 (1997). |
Z. Liang et al.,“Microfabrication of a Planar Absorbance and Florescence and Fluorescence Cell for Integrated Capillary Electrophoresis Devices,” Anal. Chen?. 68:1040-1046 (1996). |
U.S. Appl. No. 10/246,814, filed Sep. 1, 2002, Handique et al. |
U.S. Appl. No. 11/929,877, filed Oct. 30, 2007, Ganesan et al. |
Bollet, C. et al., “A simple method for the isolation of chromosomal DNA from Gram positive or acid-fast bacteria”, Nucleic Acids Research, vol. 19, No. 8 (1991), p. 1955. |
Brahmassandra, et al., On-Chip DNA Detection in Microfabricated Separation Systems, Part of the SPIE Conference on Microfludic Devices and Systems, 1998, Santa Clara, California, vol. 3515, pp. 242-251. |
Breadmore, M.C. et al., “Microchip-Based Purification of DNA from Biological Samples”, Anal. Chem., vol. 75 (2003), pp. 1880-1886. |
Brody, et al., Diffusion-Based Extraction in a Microfabricated Device, Sensors and Actuators Elsevier, 1997, vol. A58, No. 1, pp. 13-18. |
Broyles et al., “Sample Filtration, Concentration, and Separation Integrated on Microfluidic Devices” Analytical Chemistry (American Chemical Society), (2003) 75(11): 2761-2767. |
Burns et al., “An Integrated Nanoliter DNA Analysis Device”, Science 282:484-487 (1998). |
Carlen et al., “Paraffin Actuated Surface Micromachined Valve,” in IEEE MEMS 2000 Conference, Miyazaki, Japan, (Jan. 2000) pp. 381-385. |
Chung et al., “Microfluidic chip for high efficiency DNA extraction”, Miniaturisation for Chemistry, Biology & Bioengineering, vol. 4, No. 2 (Apr. 2004), pp. 141-147. |
Handique et al., On-Chip Thermopneumatic Pressure for Discrete Drop Pumping, Analytical Chemistry, American Chemical Society, Apr. 15, 2001, vol. 73, No. 8, 1831-1838. |
Handique et al, “Microfluidic flow control using selective hydrophobic patterning”, SPIE, vol. 3224, pp. 185-194 (1997). |
Handique et al., “Nanoliter-volume discrete drop injection and pumping in microfabricated chemical analysis systems”, Solid-State Sensor and Actuator Workshop (Hilton Head, South Carolina, Jun. 8-11, 1998) pp. 346-349. |
Handique et al., “Mathematical Modeling of Drop Mixing in a Slit-Type Microchannel”, J. Micromech. Microeng., 11:548-554 (2001). |
Handique et al., “Nanoliter Liquid Metering in Microchannels Using Hydrophobic Patterns”, Anal. Chem., 72:4100-4109 (2000). |
He et al., Microfabricated Filters for Microfluidic Analytical Systems, Analytical Chemistry, American Chemical Society, 1999, vol. 71, No. 7, pp. 1464-1468. |
Ibrahim, et al., Real-Time Microchip PCR for Detecting Single-Base Differences in Viral and Human DNA, Analytical Chemistry, American Chemical Society, 1998, 70(9): 2013-2017. |
Khandurina et al., Microfabricated Porous Membrane Structure for Sample Concentration and Electrophoretic Analysis, Analyt Chem., (1999) 71(9): 1815-1819. |
Kopp et al., Chemical Amplification: Continuous-Flow PCR on a Chip, www.sciencemag.org, 1998, vol. 280, pp. 1046-1048. |
Kutter et al., Solid Phase Extraction on Microfluidic Devices, J. Microcolumn Separations, John Wiley & Sons, Inc., 2000, 12(2): 93-97. |
Lagally et al., Single-Molecule DNA Amplification and Analysis in an Integrated Microfluidic Device, Analytical Chemistry, American Chemical Society, 2001, 73(3): 565-570. |
Livache, et al., “Polypyrrole DNA Chip on a Silison Device: Example of Hepatitis C Virus Genotyping,” Analytical Biochemistry, 1998, vol. 255, pp. 188-194. |
Mascini et al., “DNA electrochemical biosensors”, Fresenius J. Anal. Chem., 369: 15-22, (2001). |
Northrup et al., A Miniature Analytical Instrument for Nucleic Acids Based on Micromachined Silicon Reaction Chambers, Analytical Chemistry, American Chemical Society, 1998, 70(5): 918-922. |
Oleschuk et al., Trapping of Bead-Based Reagents within Microfluidic Systems,: On-Chip Solid-Phase Extraction and Electrochromatography, Analytical Chemistry, American Chemical Society, 2000, 72(3): 585-590. |
Plambeck et al., “Electrochemical Studies of Antitumor Antibiotics”, J. Electrochem Soc.: Electrochemical Science and Technology (1984), 131(11): 2556-2563. |
Roche et al. “Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells” Faseb J (2005) 19: 1341-1343. |
Ross et al., “Analysis of DNA Fragments from Conventional and Microfabricated PCR Devices Using Delayed Extraction MALDI-TOF Mass Spectrometry”, Analyt Chem. 1998, 70(10): 2067-2073. |
Shoffner et al., Chip PCR.I. Surface Passivation of Microfabricated Silicon-Glass Chips for PCR, Nucleic Acids Research, Oxford University Press, 1996, vol. 24, No. 2, 375-379. |
Smith et al., “Comparison of Commercial DNA Extraction Kits for Extraction of Bacterial Genomic DNA from Whole-Blood Samples”, Journal of Clinical Microbiology, vol. 41, No. 6 (Jun. 2003), pp. 2440-2443. |
Wang, “Survey and Summary, from DNA Biosensors to Gene Chips”, Nucleic Acids Research, 28(16):3011-3016, (2000). |
Waters et al., Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing, Analytical Chemistry, American Chemical Society, 1998, 70(1): 158-162. |
Weigl et al., Microfluidic Diffusion-Based Separation and Detection, www.sciencemag.org, 1999, 283: 346-347. |
Yoza et al., “Fully Automated DNA Extraction from Blood Using Magnetic Particles Modified with a Hyperbranched Polyamidomine Dendrimer”, Journal of Bioscience and Bioengineering, 2003, 95(1): 1-26. |
Yoza et al., DNA extraction using bacterial magnetic particles modified with hyperbranched polyamidoamine dendrimer, Mar. 20, 2003, 101(3): 219-228. |
Number | Date | Country | |
---|---|---|---|
20120077231 A1 | Mar 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11119539 | Apr 2005 | US |
Child | 13311087 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09517680 | Mar 2000 | US |
Child | 11119539 | US | |
Parent | 08888309 | Jul 1997 | US |
Child | 09517680 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 08529293 | Sep 1995 | US |
Child | 08888309 | US |